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INTRODUCTION 
 
Seas and oceans represent an endless source of compounds with interesting 
pharmacological activity. The remarkable biodiversity within the marine 
environment is proven by the coexistence of an enormous number of 
species, which interact with each other and with the environment in 
different ways. In this process, chemistry plays an essential role; all the 
marine organisms synthesize or obtain from symbiotic microorganisms 
“secondary metabolites”, molecules with even very complex structures, 
which are characteristic of specific species or specific taxa. Many secondary 
metabolites are involved in the interactions within or between species. 
Considering the number of different species and their immeasurable 
possible interactions, it’s not a surprise that a wide variety of secondary 
metabolites are produced to preserve and improve the life of the producing 
organisms.   
It’s very well known that plants are particularly rich in secondary 
metabolites, and their properties have been long exploited for the treatment 
of diseases. In the last decades, the progress in some technologies and the 
wider availability of diving equipment made it possible to extend this 
research to marine organisms.  
A larger number of organisms and less genetic homogeneity between 
separate populations of the same species exist in the marine compared to the 
terrestrial environment. This results in a higher structural diversity at the 
molecular level. Among marine organisms, the chance of finding bioactive 
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compounds is remarkably higher in some invertebrates, like corals, 
tunicates, and sponges. Many of these compounds are involved in their 
chemical defence, which is essential for the survival of sessile organism, 
often lacking any physical defence from their predators.  
  Even when showing interesting and specific pharmacological 
activities, natural compounds isolated from marine organisms rarely raise 
the interest of pharmaceuticals companies, because they are difficult to 
obtain in sufficient amounts for clinical use. Total synthesis is a possible 
way to overcome this problem, but this is usually prevented by the complex 
structure of most natural products, often including many chiral centers, 
which makes this option economically unfeasible. 
In this case, tapping the natural source is the best option. The 
problem is to conciliate development dynamics necessary for man and 
protection of the marine environment and biodiversity. Oceans are showing 
increasing signs of overexploitation and degradation, resulting in loss of 
both productivity and biodiversity. In this context, a massive collection of 
marine organisms producing compounds of industrial interest appears 
unrealistic. Alternative approaches have therefore been proposed, such as 
the cultivation of the organism of interest under controlled conditions 
(aquaculture), and the laboratory production of metabolites in bioreactors 
from cell cultures.  
A more recent approach, which in the light of the explosive 
development of molecular biotechnologies is rapidly gaining a prominent 
position worldwide, is the study of the metabolic processes leading to the 
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synthesis of secondary metabolites. The understanding of these processes at 
the genetic level is paving the way to the possibility to control them, and 
eventually to produce the desired metabolites in large scale using a "green 
technology" such as gene cloning.  
The research work described in this PhD Thesis was performed at 
the Dipartimento di Chimica delle Sostanze Naturali of Università di 
Napoli "Federico II", and was directed to different aspects of the research 
on marine natural products. On one hand, part of the research was directed 
to the "core activity" of natural product chemistry, i.e. isolation and 
structure elucidation of new compounds from marine organisms and their 
symbiotic microorganisms. In this respect, particular attention was paid to 
glycolipids from sponges, and several structurally interesting new 
glycosphingolipids were isolated from the marine sponges Terpios sp. and 
Amphimedon compressa. 
On the other hand, a new research line was started up that focused 
on the study of the biosynthetic pathway of plakortin, polyketide peroxide 
with interesting antimalarial properties which is present in the marine 
sponge Plakortis simplex and is probably produced by an unculturable 
symbiotic microorganism of the sponge. The aim of this work was to 
identify and isolate the biosynthetic gene cluster fort his compounds, with 
the future objective of expressing the pathway heterologously to produce 
plakortin by fermentation. 
Therefore, the results of research work sketched above have been 
organized into two sections:   
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 Isolation and structure elucidation of glycolipids from the 
marine sponges Amphimedon compressa and Terpios sp. 
 Study of the biosynthetic pathway of plakortin from the 
marine sponge Plakortis simplex. 
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Chapter 1 
Porifera 
Porifera commonly known as sponges are the simplest and ancient 
phylum among metazoans. They are ubiquitous animals and live 
permanently attached to a location in the water. There are from 5,000 to 
10,000 known species of sponges. Most sponges live in salt water; only 
about 150 species live in fresh water.  
Their body consists of specialized tube-like cells called porocytes which 
control channels leading to the interior of mesohyl (ostia).  
 
 
Figure 1: A sponge body structure  
 
Mesohyl is the gelatinous matrix within the sponge made of collagen and 
covered by choanocytes, cylindrical flagellated cells. The outer layer is 
formed by pinacocytes, plate-like cells which digest food particles too large 
to enter the ostia. The body is reinforced by the skeleton, collagen fibers and 
spicules: Calcareous sponges produce spicules made of silica calcium 
carbonate while the larger class (90%) of Demonspongiae produce a special
mesohyl 
osculum 
pinacocytes 
choanocytes 
ostia 
skeleton
 Porifera
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form of collagen called spongin besides silica spicules; glass sponges, 
common in polar water and in the depths of temperate and tropical seas 
contain synctia in their structure which enable them to extract food from 
these resource-poor waters with the minimum of effort. Sponges are filters 
feeders; they obtain nourishment, tiny and floating organic particles, 
plankton and oxygen from flowing water that they filter through their body.  
Water flows into a sponge through porocytes and flows out of it through 
large opening called oscula. The flowing water also carries out waste 
products. 
The simplest body structure in sponges is a tube or vase shape known as 
asconoid; in siconoids the body wall is pleated and the pumping capacity is 
increased; leuconoids contain a network of chambers lined with choanocytes 
and connected to each other and to the water intakes and outlet by tubes.  
                         
Figure 2: Sponge classification: a. asconoid; b. siconoids; c. leuconoids 
 
Most sponges are hermaphrodites (each adult can act as either the 
female or the male in reproduction). Fertilization is internal in most species; 
some released sperm randomly float to another sponge with the water 
current. If a sperm is caught by another sponge's collar cells (choanocytes), 
fertilization of an egg by the travelling sperm takes place inside the sponge.
b. c. a. 
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The resulting tiny larva is released and is free-swimming; it uses tiny cilia 
(hairs) to propel itself through the water. The larva eventually settles on the 
sea floor, becomes sessile and grows into an adult.  
Some sponges also reproduce asexually; fragments of their body (buds) 
are broken off by water currents and carried to another location, where the 
sponge will grow into a clone of the parent sponge (its DNA is identical to 
the parent's DNA).  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 3: Sponges discussed in this PhD Thesis: Plakortis simplex, 
Amphimedon compressa and Terpios sp. 
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Chapter 2 
Structural Determination Methods 
Until a few decades ago structural determination of new organic 
compounds was only pursued through the use of chemical techniques 
(degradation and interconversion of functional groups). The development of 
spectroscopic techniques dramatically changed this approach. Today, it is 
possible to determine complex organic structures completely in a non-
destructive way, with submilligram samples. Structural determination 
described in this thesis is largely based on spectroscopic techniques, mostly 
mass spectrometry (MS) and nuclear magnetic resonance (NMR), even if in 
some cases degradation methods were used.  
2.1 Mass Spectrometry 
The first step in the study of a new bioactive compound is the 
determination of the molecular formula through the high resolution mass 
spectrometry.  
Mass spectrometry is an analytical technique that is used to determine 
the molecular mass of a compound on the basis of the mass-to-charge ratio 
(m/z ratio) of ions produced from the molecules. A very accurate 
measurement of the molecular mass (high resolution mass spectrometry) can 
also provide the molecular formula of the molecule under study. 
The source is the component of the mass spectrometer which produces 
ions from the molecule, while the analyzer measures the mass-to-charge
 Structural Determination Methods
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ratio of the ions. There are many different types of sources, as well as of 
analyzers. 
During or after ionization the molecule may fragment, and the mass of 
the fragments provides information on the structure of the molecule under 
examination. If the ions do not fragment by themselves, they may be 
induced to fragment by letting them collide with gas molecules. In this case, 
a second analyzer is used to measure the mass of the fragments. This is 
known as tandem mass spectrometry or MS/MS. 
Most of compounds described in the following sections were analyzed 
by ESI mass spectrometry. The ESI source is a widely used technique for 
polar and/or charged macromolecules. The sample is dissolved in a volatile 
solvent like H2O, MeOH, and CH3CN; volatile acids, bases or buffers are 
often added to the solution. This solution is pumped through a charged 
metal capillary and, in coming out of the capillary, forms a spray. Because 
of the electric potential of the capillary, each droplet of the spray carries an 
excess positive or negative charge, and this causes extensive protonation or 
deprotonation of the molecules of the sample, which become ions. An 
uncharged carrier gas such as nitrogen is used to help the liquid to nebulize 
and the neutral solvent in the droplets to evaporate.  
As the solvent evaporates, the ionized analyte molecules become closer 
and closer, until they can escape from the droplet by electrostatic repulsion. 
For molecules with a high molecular weight, the ions may take more than 
one proton (up to some tens), and therefore may have multiple charge. 
Formation of multiply charged ions allows the analysis of high molecular 
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weight molecules such as proteins, because it reduces the m/z ratio of the 
ions, which is therefore easier to measure. 
2.2 Nuclear Magnetic Resonance 
 The most important spectroscopic technique used for structure 
elucidation of the isolated secondary metabolites was nuclear magnetic 
resonance (NMR). In addition to standard 
1
H and 
13
C NMR spectra, a large 
use of 2D NMR experiments was made. They are superior to their 1D NMR 
counterparts both for the shorter acquisition times, and for the easier 
assignment of nuclei resonating in crowded regions of the spectra (signal 
overlapping is much less likely in two dimensions than in one). 
The COSY (Correlation SpectroscopY) experiment is one of the 
simplest and yet most useful 2D NMR experiment. It allows determination 
of the connectivity of a molecule by identifying which protons are scalarly 
coupled. In spite of the many modifications which have been proposed 
along the years, the very basic sequence composed of two π/2 pulses 
separated by the evolution period t1 is still the best choice if one is simply 
dealing with the presence or the absence of a given coupling, but not with 
the value of the relevant coupling constant. 
The TOCSY (Total Correlation SpectroscopY) experiment is a 2D 
NMR experiment very useful in the analysis of molecules composed of 
many separate spin systems, such as oligosaccharides or peptides. The 
TOCSY spectrum shows correlation peaks between nuclei that may be not 
directly coupled, but are still within the same spin system. The appearance 
 Structural Determination Methods
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of a TOCSY spectrum resembles in all aspects a COSY; the difference is 
that the cross peaks in a COSY result from coupled spins, whereas in the 
TOCSY spectra they arise from coherence transfer through a chain of spin-
spin couplings, and therefore any pair of protons within a spin system may 
give rise to a peak. The range of the coherence transfer (i.e. through how 
many couplings the coherence may be transferred) increases with increasing 
mixing times (Δ), but a mixing time too long may reduce sensitivity. 
The HSQC (Heteronuclear Single Quantum Correlation) and HMQC 
(Heteronuclear Multiple Quantum Correlation) experiment are 2D NMR 
heteronuclear correlation experiments, in which only one-bond proton-
carbon couplings (
1
JCH) are observed. In principle, the HSQC experiment is 
superior to HMQC in terms of selectivity and additionally allows DEPT-
style spectral editing. However, the sequence is longer and contains a larger 
number of π pulses, and is therefore much more sensitive to instrumental 
imperfections than HMQC. 
The HMBC (Heteronuclear Multiple Bond Correlation) experiment is a 
heteronuclear two-and three-bond 
1
H-
13
C correlation experiment; its 
sequence is less efficient than HSQC because the involved 
2,3
JCH couplings 
are smaller (3-10Hz). Moreover, while 
1
JCH are all quite close to each other, 
2,3
JCH can be very different, making impossible to optimize the experiment 
for all couplings. As a result, in most HMBC spectra not all of the 
correlation peaks which could be expected from the structure of the 
molecule are present. 
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The ROESY (Rotating-frame Overhauser SpectroscopY) experiment is a 
chemical shift homonuclear correlation which can detect ROEs (Rotating-
frame Overhauser Effect). ROE is similar to NOE, being related to dipolar 
coupling between nuclei, and depending on the geometric distance between 
the nuclei. While NOE is positive for small molecules and negative for 
macromolecules, ROE is always positive. Therefore, the ROESY 
experiment is particularly useful for mid-size molecules, which would show 
a NOE close to zero. The ROESY sequence is similar to the TOCSY 
sequence, and unwanted TOCSY correlation peaks may be present in the 
ROESY spectra. Fortunately, these unwanted peaks can be easily 
recognized, because their phase is opposite compared to ROESY correlation 
peaks. It is important to acquire ROESY spectrum in phase-sensitive mode 
for a correct interpretation of the spectrum. 
2.3 Circular Dichroism 
Circular dichroic (CD) spectroscopy of optically active compounds is a 
powerful method for studying the three-dimensional structure of organic 
molecules, and can provide information on absolute configurations, 
conformations, reaction mechanisms, etc.  
The CD spectroscopy takes advantage of the different absorption shown 
by chiral compounds of left and right circularly polarized UV/Vis light. In 
circularly polarized light, the electric field vector rotates about its 
propagation direction forming a helix in the space while propagating. This 
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helix can be left-handed or right-handed, hence the names left and right 
circularly polarized light. 
At a given wavelength, circular dichroism of a substance is the 
difference between absorbance of left circularly polarized and right 
circularly polarized light:  
ΔA = AL - AR 
Since circular dichroism uses asymmetric electromagnetic radiations, it 
can distinguish between enantiomers. Two enantiomers have the same CD 
spectra, but with reversed sign. 
Of course, in order to show a differential absorbance, the molecules 
needs to absorb the UV/Vis light, and therefore must possess at least one 
chromophore. If the molecule does not have a chromophore, this can be 
introduced using a derivatization reaction. This is why methyl glycosides 
are benzoylated (see Chapter 3) to determine their absolute configuration. 
One of the most important methods to establish the absolute 
configuration of a molecule is the exciton chirality method. This method is 
based on the interaction between two chromophores. When two or more 
strongly absorbing chromophores are located nearby in space and constitute 
a chiral system, their electric transition moments interact spatially (exciton 
coupling) and generate a circular dichroism. Because the theoretical basis of 
exciton coupling are well understood, it is possible to correlate the CD 
spectrum of an exciton-coupled chromophore system with the spatial 
orientation of the chromophores, which in turn can be related to the absolute 
configuration of the molecule. It is important to point out that, unlike for 
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example optical rotation, the exciton chirality method does not require any 
reference compound to provide the absolute configuration of the molecule 
under study (if its conformation is known). 
  
22 
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Chapter 3 
Glycolipids 
Glycolipids represent a class of molecules of widespread diffusion in the 
animal and vegetable kingdoms; because of their chemical and biochemical 
diversity and of their biological role, they appear a very interesting class of 
compounds. Glycolipids are ubiquitous components of the cells plasmatic 
membranes, where they play different and significant functions, such as 
cellular differentiation and signal transduction modulation, as well as 
adhesion and cell-cell recognition. 
            
Figure 4: Membrane phospholipid bilayer organization 
Many studies on glycolipids demonstrated their activity on the immune 
system and their influence on angiogenesis and tumor cells proliferation, 
and therefore they are used in therapy against several diseases. Glycolipids 
are amphiphilic compounds: the polar portion of the molecule is composed 
of an oligosaccharide chain, which is the main responsible for the biological
 Glycolipids
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 role of glycolipids. It is commonly acknowledged that the bioactivity 
depends essentially on the nature of the sugar head and the adjacent 
functionalized part of the molecule. In contrast, the alkyl chains serve to 
position the glycolipid in the membrane and affect its fluidity.  
Depending on their lipophilic portion, they are currently divided into 
two groups: glycoglycerolipids (GGLs) and glycosphingolipids (GSLs). 
There is a third important group, comprising glycolipids whose lipid portion 
is derived from mevalonate, such as steroidal and terpenic glycosides. The 
occurrence of polyisoprenoidic glycolipids is generally confined to species 
belonging to a few taxa, where they frequently play peculiar biological 
functions; as for marine organisms, they are mostly present in invertebrates 
belonging to phylum Echinoderma.  
3.1 Glycosphingolipids 
The structure of a representative GSL is depicted in Figure 5. A 
carbohydrate chain and a fatty acyl group are linked to a long-chain 
aminoalcohol, called sphingoid base or long-chain base (LCB). The fatty 
acyl chain is amide-linked to the LCB, and together they make up what is 
called a ceramide; the monosaccharide or oligosaccharide group is bound to 
the primary alcoholic function of the ceramide. 
Sphingosine is the LCB most commonly found in higher animals, so 
that LCBs are often referred to as sphingosines. In plant glycolipids, the 
trihydroxylated LCB phytosphingosine is frequently found; the name 
phytosphingosine is also often used more generally, meaning any 
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trihydroxylated LCB. Since an increasing number of different sphingoid 
bases are being described in the literature, a semisystematic nomenclature 
for LCBs has been proposed, which is based on sphinganine (2-amino-1,3-
octadecandiol).
1
 
 
Figure 5: A generic glycosphingolipid   
3.2 Isolation Procedures 
A matter which appears to be worthy of a preliminary discussion is the 
level of purity of a mixture of glycolipids. Virtually all natural glycolipids 
occur as mixtures of homologues, differing in the length and in the 
branching of the alkyl chains of the lipid portion of the molecule. Often, 
structural studies are performed on the mixtures of homologues, while the 
nature of the fatty acids and/or the sphingoid bases is subsequently 
established by chemical degradation followed by GC/MS analysis. The 
difficulty (or more often the impossibility) to obtain a chemically 
homogeneous glycolipid is evident, if one considers that, for example, a 
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glycosphingolipid which appear pure by normal phase HPLC often contains 
7-8 different sphingoid bases and fatty acids, and this corresponds to over 
50 different compounds. Attempts of chromatographic separation of such 
complex mixtures are reported in the literature,
2,3 
but they afforded only a 
small number of homogenous fractions, the other ones being still mixtures 
which were characterized for the major component only, or not at all. 
Generally, a mixture of homologue glycolipids can be regarded to be a 
"single" compound, the purity being referred to the biological role of the 
material that for glycolipids depends on the saccharidic chain. 
The most recent procedures for the isolation of neutral marine glycolipids 
take advantage of their amphiphilic character; basically, the homogenate of 
the tissue is extracted with a mixture of methanol and chloroform. The 
combined extracts are usually partitioned between water and butanol, and 
the glycolipid material can be recovered in the butanol phase. The crude 
extract obtained after the evaporation of the phase is successively subjected 
to a reversed-phase column chromatography as the first step of the 
purification of the organic phase: glycolipids, in spite of their remarkable 
polarity, are conspicuously retained by the stationary phase and are eluted 
together with quite non-polar substances, which can be easily removed 
through a successive adsorption chromatography on SiO2. A relatively pure 
glycolipids fraction is therefore obtained. 
The next steps of the separation procedure must be optimized for each 
single compound. In many cases, the whole glycolipids mixture is 
acetylated, because acetylated glycolipids are easily separated on normal 
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phase HPLC and analyzed with NMR. Moreover, the acetylation reaction 
with deuterated acetic anhydride (CD3CO)2O allows one to distinguish 
between the natural acetyl groups and those introduced by the acetylation 
reaction.  
 
3.3 Structure Determination of Glycolipids 
The first reports on complete structural assignments of glycolipids from 
marine sources are relatively recent, dating from the seventies. From the 
beginning, spectroscopic data remarkably assisted chemical analysis to 
clarify the structures of these metabolites. Of course, the importance of the 
physical methods has dramatically increased during the last ten years, when 
the modern two-dimensional techniques improved the NMR spectroscopy as 
a precious tool of chemical analysis, able to provide decisive information 
Frozen Organism
Extraction with MeOH and CHCl3
Ripartition
Butanol phase
RP 18 Chromatography
Fr. A 
(H2O:MeOH)
Fr. B 
(MeOH:CHCl3)
Fr. C (CHCl3)
SiO2 Chromatography
Glycolipid fraction
Aqueous phase
Figure 6: Glycolipids isolation scheme 
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for the elucidation of complex structures, including the stereochemical 
details, with just a few milligrams of a reasonably pure product. 
According to our procedures, the starting point of the structural analysis 
of a natural product is the determination of molecular formula. This is 
currently achieved by interpretation of mass spectral data; the successive 
step involves the assignment of the structure to the lipid part of the molecule 
and to the sugar moiety, which are generally investigated in separate 
experiments and through quite different analytical techniques.  
 
Structure of the Sugar Portion 
For the analysis of the structure of the polar portion of glycolipids, two-
dimensional homonuclear (
1
H-
1
H) and heteronuclear (
1
H-
13
C) correlation 
experiments are mainly performed. The NMR studies are carried out using 
the peracetylated glycolipid because of the better proton dispersion in the 
1
H-NMR spectrum of this derivative, and the possibility of discriminating 
between ether and ester oxymethine proton resonances on the basis of their 
different chemical shift ranges (δ 3.5-4.5 and 4.7-5.7, respectively).  
The 
1
H-
13
C heteronuclear correlation (HSQC) spectrum allows to easily 
identify anomeric carbons and the corresponding anomeric protons and so 
the number of saccharidic units, because in peracetylated glycolipids 
anomeric carbons have characteristic resonances compared to the other 
oxygenated sugars carbons, being they linked to two carbon atoms instead 
of one. Methylene diasterotopic protons can also be identified because they 
are coupled with the same carbon. Starting from the anomeric proton all the 
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protons in the corresponding spin system are assigned with a TOCSY 
spectrum whereas a subsequent COSY spectrum is used to find out the 
proton sequence in each spin system. The chemical shift values of the 
protons contribute to discriminate between acetylated hydroxyl groups and 
those involved in glycosidic bonds, providing useful data to determine 
glycosylation sites and furanose or pyranose structure of each 
monosaccharide of the carbohydrate chain.  
The nature of the sugar units and the configuration of the glycosidic 
bonds are ascertained by 1H-1H coupling constants analysis. When 
coupling constant analysis is not sufficient for an unambiguous structural 
assignment, additional information can be provided by a ROESY spectrum, 
evidencing inter-proton spatial proximities.
4
 Linkages between couples of 
sugars and between the carbohydrate chain to the aglycon are evidenced by 
a long-range 
1
H-
13
C shift correlation (HMBC) experiment,
5
 which shows 
connectivity between proton and carbon atoms separated by two or three ζ 
bonds, or by the ROESY spectrum.  
 
Structure of the Ceramide Portion  
Also in this case, NMR experiments are useful to clarify the 
structure and the relative stereochemistry of the polar portion of the 
sphingosine as well as to identify alkyl chain branching. It is to be noted, 
however, that as said above the material to be investigated is often a mixture 
of homologues differing in the lipid part of the molecule, and this requires 
the use of appropriate analytical procedures. 
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Sphingoid bases are normally removed from the molecule by treatment with 
acidic methanol, then purified through a SiO2 column chromatography, and 
identified and quantitized as free bases or as appropriate derivatives by GC 
analysis.
6
 If reference compounds are not available, the identification can be 
accomplished by periodate/permanganate oxidation
7
 followed by 
methylation
8
 of the sphingosine homologues, and gas-chromatographic 
identification of the resulting fatty acid methyl esters. 
 
Absolute configuration 
Absolute configuration can be assigned to sphingosines, α-hydroxyacids, 
and methyl glycosides through Circular Dichroism (CD) measurements. 
Methanolysis of GSLs provides a mixture of fatty acid methyl esters and/or 
-hydroxyacid methyl esters, sphingosines and methyl glycosides. The 
mixture is benzoylated and separated on normal phase HPLC, so that 
individual compounds can be analyzed separately. Their 
1
H NMR and CD 
spectra are recorded and compared with those of authentic sample of known 
stereochemistry.   
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          Figure 7: Microscale degradation scheme 
Glycosphingolipid
Methanolysis with HCl 1M in MeOH (92%), 70o C, 12h
SiO2 Chromatography
FAM
(GC-MS)
Sphingosine
Oxidation with KMnO4/NaIO4
Cn-3 Carboxilic Acids
Methylation
Methyl Esters 
(GC-MS)
Methyl 
Glycosides
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Chapter 4 
Terpioside A 
 
from the Marine Sponge Terpios sp.
 
  The new and interesting GSL terpioside A (1a)
1
 was isolated from the 
Caribbean sponge Terpios sp. It is the first example of a natural 
diglycosylceramide having a L-fucofuranose unit in the sugar chain of the 
molecule. 
 
Figure 8: Structure of terpioside from  the sponge Terpios sp. 
                   
4.1 Isolation of Terpioside 
 Samples of Terpios sp. were collected along the coast of Key Largo 
(Florida) and kept frozen until extraction. The specimens were extracted 
three times with methanol and then with chloroform. The methanol extract 
was partitioned between water and BuOH, in order to separate lipophilic 
metabolites as glycolipids from hydrophilic molecules as proteins and 
sugars. The organic phase was dried, and according to our standard
procedure a glycolipid fraction was obtained by subsequent reversed phase 
and normal phase column chromatography. The glycolipid fraction was 
1a  R = H  
1b  R = CH3CO 
1c  R = CD3CO 
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acetylated, and the peracetylated glycolipids were subjected to repeated 
HPLC on SiO2 columns to give 62.6 mg of compound 1b. This was 
deacetylated with MeOH/MeONa to yield the natural glycolipid 1a.  
4.2 Structure Determination of Terpioside 
Extensive NMR techniques, microscale degradation and mass 
spectrometric analysis were used to establish the structure of terpioside A 
(1a).  
Natural terpioside 1a was subjected to mass spectrometric experiments. 
The ESI mass spectrum of compound 1a showed a series of sodiated 
pseudomolecular ion peaks at m/z = 986, 1000, 1014, 1028 1042, and 1056, 
which suggested a series of homologues differing in the size of the alkyl 
chains. A high-resolution measurement performed on the most abundant ion 
at m/z = 1028.7567 indicated the molecular formula C55H107NO14 for the 
dominant homologue.  
A preliminary analysis of the 
1
H NMR spectrum of the peracetyl 
derivative (1b) showed it to be a glycosphingolipid, as suggested by: 
 an strong aliphatic chain signal at δ 1.25  
 an amide NH doublet at δ 6.76  
 several signals due to oxymethine and oxymethilene groups between  
5.4 e 3.4. 
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Figure 9: 
1
H NMR spectrum of peracetyl terpioside (1b) 
 in CDCl3 at 400MHz 
 
The 
1
H NMR spectrum also showed in the methyl region a triplet at δ 0.87 
(ethyl terminus) and a doublet at δ 0.85 ppm (isopropyl terminus), the 
intensities of which were not in an integral ratio relative to those of other 
signals in the spectrum. This showed that the alkyl chains differ not only in 
the length, but also in the branching of the alkyl chains.
  
 
Planar Structure 
More detailed analysis of one- and two-dimensional NMR spectra showed 
that the ceramide portion of the molecule is composed of a 3,4-
dihydroxysphinganine and an α-hydroxy fatty acid residue. Starting from 
the amide NH doublet at δ 6.78 (2-NH) all the protons of the polar part of 
the sphinganine from H2-1 up to H2-6 were assigned by analysis of the 
COSY spectrum (Table 1). The α-hydroxy substitution of the fatty acid 
residue was revealed by the absence in the 
1
H NMR spectrum of 1b of the 
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characteristic triplet at δ 2.3 for the fatty acid α-protons, whereas the 
spectrum displayed an acetoxymethine proton resonance at δ 5.17 (2ΙΙΙ-H) 
coupled with a methylene resonance at δ 1.83 ppm (3ΙΙΙ-H), in turn coupled 
with proton resonances in the broad signal, relative to alkyl chain protons, at 
δ 1.24.  
         
Figure 10: 2D NMR COSY spectrum of the compoud 1b 
in CDCl3 at 400MHz 
 
Evidence that the sphingosine was linked to the fatty acid was provided 
by the ROESY spectrum. In the ROESY spectrum of compound 1b the 
oxymethine proton at δ 5.17 (2ΙΙΙ-H) showed a correlation peak with the NH 
doublet at δ 6.78. This demonstrated the amide bond between the α-hydroxy 
fatty acid carbonyl and the sphingosine and completed the planar structure 
determination of the ceramide portion of the molecule.  
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Figure 11: 2D NMR ROESY spectrum of terpioside (1b) 
 in CDCl3 at 500MHz 
 
The two sugar units were revealed by the presence of two anomeric 
carbons in the 
13
C NMR spectrum at δ 100.1 (C-1) and 100.8 (C-1IΙ). 
Anomeric carbons have characteristic resonances around δ 100, instead of δ 
60-75 as the other oxygenated sugars carbons because they are linked to two 
oxygen atoms. They were correlated through the HSQC spectrum with the 
corresponding anomeric protons, resonating as doublets at δ 4.32 (1I-H) and 
5.23 (1
II
-H).  
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Figure 12: 2D NMR HSQC spectrum of peracetylated terpioside (1b) 
in CDCl3 at 500MHz 
 
Starting from the anomeric proton doublet at  4.30, it was possible 
to assign through the COSY and TOCSY spectra the signals of all the 
protons in the first monosaccharide unit: four oxymethine protons [δ 4.81, 
3.83, 4.97 and 3.53 (2
I
-H, 3
I
-H, 4
I
-H e 5
I
-H)] and a couple of oxymethylene 
protons (6
I
-H), suggesting it is a hexose.  
The ROESY e HMBC spectra indicated that this sugar unit is linked to the 
primary hydroxyl group of the ceramide, as shown by the ROESY 
correlation peak of 1
I
-H with 1-Ha e 1-Hb and by the HMBC correlation 
peak between 1
I
-H and C-1. 
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Figure 13: Mid-field region of the 2D NMR HMBC spectrum of terpioside 
(1b) in CDCl3 at 500MHz 
 
In addition, the deshielded chemical shift of the oxymethine protons 
at the 2
I
-, 4
I
-, and 6
I
- positions indicated that the relevant hydroxy groups 
are acetylated. In contrast, the high-field chemical shift of 3
I
-H (δ 3.83) 
suggested glycosylation at this position, whereas the high-field chemical 
shift of the 5
I
-H (δ 3.51) confirmed that the relevant carbon atom C-5I is 
involved in the pyranose acetal function.  
Similarly, the second sugar spin system was recognized from the 
TOCSY and COSY experiments as that of a 6-deoxyhexose. This was 
indicated by the methyl doublet at δ 1.21 (6II-H3), which pointed to the 
presence of a methyl group at the 6-position instead of the usual –CH2OH 
group.  
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Figure 14: The spin systems of the two sugars spectrum of compound (1b) 
evidenced by the z-TOCSY spectrum (CDCl3, 500MHz) 
 
The high-field chemical shift of the 4
II
-H signal (δ 3.79), compared with the 
low-field chemical shift of the 5
II
-H signal (δ 4.96), clearly indicated that C-
4
II
 links an oxygen atom involved in an acetal function instead of an ester 
function; thus, the sugar must be in the furanose form and not in the more 
common pyranose form. This second sugar unit is linked to the first sugar at 
position 3, as shown by the HMBC correlation between C-1
II
 and 3
I
-H and 
the ROESY correlation between 1
II
-H and 3
I
-H. 
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Table 1: 
1
H and 
13
C NMR spectroscopic data of  terpioside peracetate 1b (CDCl3) 
 
 
 
  
                                                 
a. Additional 
1
H signals: δ 1.24 (br., alkyl chain protons), 0.87 (t, J = 7.0 
Hz, n-chain Me groups), 0.85 (d, J = 6.5 Hz, iso-chain Me groups) ppm.  
b. Additional 13C signals: δ 31.9 (CH2, ω-2), 22.7 (CH2, ω-1), 22.7 (CH3, iso-chain 
Me groups), 14.1 (CH3, ω) ppm. 
 
 
Position  δH  (mult, J (Hz))
1 δC (mult)
2
   
1 a 3.80  (dd, 10.4, 2.9) 66.0 (CH2) 
 b 3.61  (dd, 10.4, 3.4)  
2  4.27 (m) 47.9 (CH) 
2-NH  6.78 (d, 9.0) - 
3  5.12 (dd, 8.4, 3.2) 71.7 (CH) 
4  4.89  (ddd, 10.0, 3.2, 3.2) 73.0 (CH) 
5  1.59 (m) 28.5 (CH2) 
6 a 1.30 (m) 25.6 (CH2) 
 b 1.19 (m)  
1'  4.32
 
(d, 8.0)
 
 100.1 (CH) 
2'  4.81 (dd, 9.5, 8.0) 72.0 (CH) 
3'  3.83  (t, 9.5) 79.3 (CH) 
4
'  
4.97 (t, 9.5) 69.6 (CH) 
5'  3.53 (ddd, 9.5, 3.9, 3.9) 72.3 (CH) 
6' a 4.12 (m) 62.3 (CH2) 
1''  5.23 (d, 4.6) 100.8 (CH) 
2''  5.06 (dd, 6.3, 4.6)
 
75.2 (CH) 
3''  5.28  (t, 6.3) 73.5 (CH) 
4''  3.79  (t, 6.3) 80.4 (CH) 
5''  4.96 (dd, 6.6, 6.3) 69.6 (CH2) 
6''  1.21 (d, 6.6) 15.5 (CH3) 
1'''  -  169.7 (C) 
2'''  5.17 (dd, 6.8, 4.9)
 
73.6 (CH) 
3'''  1.83 (m) 31.8 (CH2) 
4'''  1.32 (m) 24.7 (CH2) 
Ac’s CH3 2.22, 2.09, 2.08, 2.08, 2.06, 2.10, 
2.05, 2.03 
21.0-20.6 (CH3) 
 CO - 170.9-169.1 
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Stereostructure and Alkyl Chain 
The analysis of coupling constants is a useful method to elucidate the 
relative configurations of the chiral centers of sugars in the pyranose form 
and, consequently, to establish the nature of the sugar. In our case, the first 
hexose unit was readily recognized as a β-glucopyranoside because of the 
large coupling constants between all the pairs of vicinal ring protons which 
pointed to their axial orientation.  
 
Figure 15: Mid-field region of the 2D NMR ROESY spectrum of terpioside 
(1b) in CDCl3 at 500MHz 
 
As for the furanose sugar unit, the ROESY spectrum showed correlation 
peaks between 1
II
-H/4
II
-H, 2
II
-H/4
II
-H e 3
II
-H/5
II
-H, which indicated that 1
II
-
H, 2
II
-H e 4
II
-H lie on the same side of the five-membered ring, whereas 3
II
-
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H and the CHOHCH3 group at C-4
II
 are on the other side. The configuration 
at C-5 could not be established on the basis of the ROESY data, so the sugar 
could be either an α-fucofuranoside (6-deoxy-α-galactofuranoside) or a 6-
deoxy-β-altrofuranoside. Degradation analysis showed the former to be the 
case.  
The remaining structural features of terpioside were established by chemical 
degradation. The natural glycolipid 1a was subjected to acidic methanolysis, 
and the reaction products were separated, perbenzoylated, and analyzed by 
CD and GC-MS (Scheme 1).  
 
 
 
 
Scheme 1: Microscale degradation analysis of terpioside A (1a) 
 
1a 
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This procedure, set up in our laboratory,
2
 allowed us to establish the 
absolute configuration of each sugar and that of the hydroxy acid, and the 
relative and absolute configurations of the phytosphingosine, as well as to 
identify the alkyl chains of sphingosines (Table 2) and fatty acids (Table 3). 
 
 
Table 2: Sphinganine composition of terpioside 1a  
 
 
Table 3: Fatty acid composition of terpioside A 1a 
 
In particular, analysis of the perbenzoylated methyl glycoside fraction 
led to the isolation of the 6-deoxyglycoside 3, which was tentatively 
identified as tri-O-benzoyl-α-fucopyranoside on the basis of its 1H NMR 
spectrum. An authentic sample of tri-O-benzoyl-α-fucopyranoside was 
prepared from L-fucose by acidic methanolysis and subsequent 
Sphinganine 
Comp. 
[%] 
(2S,3S,4R)-2-Amino-16-methyl-1,3,4-heptadecanetriol (iso-C18) 4.5 
(2S,3S,4R)-2-Amino-15-methyl-1,3,4-heptadecanetriol (ante-iso-C18) 15.5 
(2S,3S,4R)-2-Amino-1,3,4-octadecanetriol (n-C18) 4.1 
(2S,3S,4R)-2-Amino-16-methyl-1,3,4-octadecanetriol (iso-C19) 70.1 
(2S,3S,4R)-2-Amino-1,3,4-nonadecanetriol (n-C19) 5.8 
Fatty acid methyl esters 
Composition 
[%] 
Methyl 2-hydroxy-20-methylenicosanoate (iso-C22)  3.6 
Metyil 2-idrossidocosanoate (n-C22) 1.7 
Methyl 2-hydroxy-21-methyldocosanoate (iso-C23) 17.0 
Methyl 2-hydroxy-20-methyldocosanoate (ante-iso-C23) 4.2 
Methyl 2-hydroxytricosanoate (n-C23) 4.4 
Methyl 2-hydroxy-22-methyltricosanoate (iso-C24) 2.2 
Methyl 2-hydroxy-21-methyltricosanoate (ante-iso-C24) 5.3 
Methyl 2-hydroxytetracosanoate (n-C24) 22.3 
Methyl 2-hydroxy-23-methyltetracosanoate (iso-C25) 15.5 
Methyl 2-hydroxy-22-methyltetracosanoate (ante-iso-C25) 5.0 
Methyl 2-hydroxypentacosanoate (n-C25) 11.7 
Methyl 2-hydroxy-24-methylpentacosanoate (iso-C26) 3.2 
Methyl 2-hydroxy-23-methylpentacosanoate (ante-iso-C26) 1.8 
Methyl 2-hydroxyesacosanoate (n-C26) 2.1 
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perbenzoylation, and its 
1
H NMR and CD spectra were recorded. The 
spectra were identical to those of compound 3, thus confirming that the 
outer sugar of terpioside is a fucose and showing that its absolute 
configuration is L.  
 
 
 
 
Figure 16: 
1
H NMR spectrum of synthetic benzoylated L-fucose  
 
 
 
 
Figure 17: CD spectrum (MeCN) of Methyl tri-O-benzoyl-α-fucopiranoside (3) 
from L-fucose (dashed line) and terpioside 1a (solid line) 
 
Once the structure of the peracetyl derivative 1b had been 
elucidated, the one- and two-dimensional NMR spectra of the natural GSL 
1a were recorded and analyzed. The information provided by the COSY and 
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HMQC NMR spectra of 1a confirmed all the structural features determined 
for its peracetylated derivative and allowed the assignment of all the 
resonances in its 
1
H and 
13
C NMR spectra (Exp. Sect.).  
To make it sure that no acetyl groups were present in the natural 
terpioside 1a before the peracetylation reaction used for its isolation, we 
performed the acetylation reaction on the glycolipid fraction using 
trideuterioacetic anhydride, and then purified the mixture to give the 
deuterio derivative 1c. The 
1
H NMR spectrum of 1c was identical to that of 
1b, except that no acetyl methyl singlet was present. 
4.3 Experimental Section 
Collection, Extraction, and Isolation: Specimens of Terpios sp. were 
collected in December 2005 from along Key Largo coast (Florida) and 
identified by Prof. S. Zea (University of Colombia). They were frozen 
immediately after collection and kept frozen until extraction. The sponge 
(220 g of dry weight after extraction) was homogenized and extracted with 
methanol (3x1L), and then with chloroform (3x1 L); the combined extracts 
were partitioned between H2O and n-BuOH. The organic layer was 
concentrated in vacuo and afforded 20 g of dark green oil, which was 
purified by chromatography on a column packed with RP-18 silica gel. A 
fraction eluted with CHCl3 (5.9 g) was further purified by chromatography 
on an SiO2 column, giving a fraction [820 mg; eluent: EtOAc/MeOH (7:3)] 
mainly composed of glycolipids. This fraction was peracetylated with Ac2O 
in pyridine for 12 h. The acetylated glycolipids were subjected to HPLC 
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separation on an SiO2 column [eluent: n-hexane/EtOAc (6:4)], thus 
affording 62 mg of terpioside peracetate 1b. 
 
Terpioside Peracetate 1b: Colorless oil, [α]25D = –8 (c = 0.15, CHCl3). ESI-
MS (positive ion mode, MeOH): m/z = 1434, 1420, 1406, 1392, 1378, 1364 
([M + Na]
+
 series). 
1
H and 
13
C NMR: Table 1. Composition of the 
sphinganines: Table 2. Composition of the fatty acids: Table 3. 
 
Deacetylation of 1b: Compound 1b (30 mg) was dissolved in MeOH (950 
μL) and a 0.4 M solution of MeONa in MeOH (50 μL) was added. The 
reaction was allowed to proceed at 25 °C for 18 h and then the reaction 
mixture was dried under nitrogen and the residue partitioned between water 
and chloroform. After removal of the solvent, the organic layer gave 22 mg 
of the native glycosphingolipid 1a. 
 
Terpioside (1a): Colorless amorphous solid, [α]25D = –25 (c = 0.15, MeOH). 
HR-MS (ESI, positive ion mode, MeOH): calcd. for [C55H107NNaO14]
+ 
1028.7589; found 1028.7567 [M + Na]
+
. 
1
H NMR ([D5]piridine): δ 0.86 (n- 
and iso-chain Me groups), 1.28 (large band, alkyl chains), 1.54 (d, J = 6.5 
Hz, 3 H, 6
II
-H), 1.65 (m, 1 H, 6-Hb), 1.69 (m, 1 H, 4
III
-Hb), 1.75 (m, 1 H, 
4
III
-Ha), 1.88 (m, 1 H, 5-Hb), 1.90 (m, 1 H, 5-Ha), 1.99 (m, 1 H, 3
III
-Hb), 
2.22 (m, 1 H, 5-Ha), 3.75 (m, 1 H, 5
I
-H), 3.95 (ddd, J = 7.8, 7.8, 3.7 Hz, 1 
H, 2
I
-H), 4.08 (ddd, J = 9.2, 9.2, 3.5 Hz, 1 H, 4
I
-H), 4.15 (m, 1H, 4-H), 4.16 
(overlapped, 4
II
-H), 4.23 (overlapped, 3
I
-H), 4.24 (overlapped, 6
I
-Hb), 4.26 
(m, 1 H, 3-H), 4.36 (overlapped, 5
II
-H), 4.56 (m, 1 H, 2
III
-H), 4.47 (dd, J = 
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10.8 and 7.0 Hz, 1 H, 1-Ha), 4.65 (dd, J = 10.8, 3.9 Hz, 1 H, 1-Hb), 4.85 (d, 
J = 7.9 Hz, 1 H, 1
I
-H), 5.24 (m, 2-H), 6.08 (br. s, 1 H, 4-OH), 6.14 (d, J = 
4.5 Hz, 1 H, 1
II
-H), 6.25 (br. s, 1 H, 2
II
-OH), 6.43 (br. s, 1 H, 6
I
-OH), 6.53 
(br. s, 1 H, 5
II
-OH), 6.86 (br. s, 1 H, 3-OH), 7.10 (br. s, 1 H, 4
I
- OH), 7.36 
(br. s, 1 H, 2
I
-OH), 7.45 (br. s, 1 H, 3
II
-OH), 7.73 (br.s, 1 H, 2
III
-OH), 8.53 
(d, J = 9.5 Hz, 1 H, 2-NH) ppm. 
13
C NMR ([D5]pyridine): δ 14.3 (CH3, n-
chain Me groups), 20.6 (CH3, C-6
II
), 22.8 (CH3, iso-chain Me groups), 22.9 
(CH2, n-chain ω-1 CH2 groups), 25.6 (CH2, C-4
III
), 26.3 (CH2, C-6), 30.5–
29.5 (several CH2, alkyl chains), 32.1 (CH2, n-chain ω-2 CH2 groups), 33.8 
(CH2, C-5), 35.3 (CH2, C-3
III
), 51.4 (CH, C-2), 61.9 (CH2, C-6
I
), 65.9 (CH, 
C-5
II
), 61.9 (CH2, C-6
I
), 69.2 (CH, C-4
I
), 72.1 (CH, C- 4; CH, C-2
III
), 74.9 
(CH, C-3
II
), 77.9 (CH, C-5
I
), 79.2 (CH, C-2
II
), 84.1 (CH, C-3
I
), 86.4 (CH, 
C-4
II
), 105.1 (CH, C-1
I
), 103.1 (CH, C-1
II
), 105.3 (CH, C-1
I
), 175.3 (C, C-
1
III
) ppm. Composition of the sphinganines: Table 2. Composition of the 
fatty acids: Table 3.  
 
Methanolysis of 1a: Compound 1a (100 μg) was dissolved in 1 N HCl in 
91% MeOH (500 μL), and the solution obtained was kept in a sealed tube at 
80 °C for about 12 h. The reaction mixture was dried under nitrogen and 
partitioned between CHCl3 and H2O/ MeOH (8:2). The aqueous layer was 
concentrated to give a mixture of methyl glycosides (Fraction A), whereas 
the organic layer contained a mixture of α-hydroxy acid methyl esters and 
sphinganines (Fraction B). 
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Methyl Tri-O-benzoyl-α-L-fucopyranoside (3): L-Fucose (2.0 mg) was 
subjected to acidic methanolysis as described above. The resulting methyl 
glycosides were benzoylated with benzoyl chloride (50 μL) in pyridine (500 
μL) at 25 °C for 16 h. The reaction was then quenched with MeOH; after 30 
min, the mixture was dried under nitrogen. Methyl benzoate was removed 
by keeping the residue under vacuum with an oil pump for 24 h. The residue 
was purified by HPLC [column: Luna SiO2, 5 μ; eluent: n-hexane/ iPrOH 
(99:1); flow: 1 mLmin
–1
; UV detector: 280 nm] affording the glycoside 3 (tR 
= 6.6 min). 
1
H NMR (CDCl3): δ 1.29 (d, J = 6.5 Hz, 3 H, 6-H), 3.47 (s, 3 H, 
OMe), 4.39 (br. q, J = 6.5 Hz, 1 H, 5-H), 5.24 (d, J = 3.6 Hz, 1 H, 1-H), 5.64 
(dd, J = 10.7, 3.6 Hz, 1 H, 2-H), 5.76 (br. d, J = 3.4 Hz, 1 H, 4-H), 5.95 (dd, 
J = 10.7, 3.4 Hz, 1 H, 3-H), 7.24 (t, J = 7.7 Hz, 2 H, benzoyl meta protons), 
7.37 (t, J = 7.4 Hz, 2 H, benzoyl meta protons), 7.42 (t, J = 7.6 Hz, 1 H, 
benzoyl para proton), 7.53–7.45 (overlapping signals, 3 H, benzoyl 
protons), 7.61 (t, J = 7.5 Hz, 1 H, benzoyl para proton), 7.79 (d, J = 7.9 Hz, 
2 H, benzoyl ortho protons), 7.98 (d, J = 7.9 Hz, 2 H, benzoyl ortho 
protons), 8.11 (d, J = 8.0 Hz, 2 H, benzoyl ortho protons) ppm. CD 
(MeCN): λmax = 237 (Δε = –42), 222 (Δε = +14) nm. 
 
Absolute Stereochemistry of Methyl Glycosides from Compound 6a: 
Fraction A from the methanolysis of compound 1a was benzoylated with 
benzoyl chloride (20 μL) in pyridine (200 μL) at 25 °C for 16 h. The 
reaction was then quenched with MeOH; after 30 min, the mixture was 
dried under nitrogen. Methyl benzoate was removed by keeping the residue 
under vacuum with an oil pump for 24 h. The residue was purified by HPLC 
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[column: Luna SiO2, 5 μ; eluent: n-hexane/iPrOH (99:1); flow: 1 mL min
–1
]. 
The chromatogram showed two peaks: methyl tetra-O-benzoyl-α-D-
glucopyranoside (2), identified by comparison of its 
1
H NMR and CD 
spectra with those reported in the literature,
2
 and methyl tri-O-benzoyl- α-L- 
fucopyranoside (3), identified by comparison of its 
1
H NMR and CD spectra 
with those of the authentic samples prepared from L-fucose. 
 
Analysis of Fatty Acid Methyl Esters: Fraction B from the methanolysis of 
compound 1a was analyzed by GLC-MS and its components identified by 
comparison of their retention times and mass spectra with those of authentic 
samples. The results are compiled in Table 3. 
 
Analysis of Fraction B: Fraction B from the methanolysis of compounds 1a 
was benzoylated as described above and the crude product of the reaction 
was purified by HPLC [column: Luna SiO2, 5 μ; eluent: n-hexane/iPrOH 
(99:1); flow: 1 mLmin
–1
]. The chromatogram shows two peaks, which were 
identified as a mixture of  homologues of  benzoylated fatty acid methyl 
esters (fraction C, tR = 4.0 min) and a mixture of perbenzoylated 
sphinganines (Fraction D, tR = 6.9 min) on the basis of their respective 
1
H 
NMR spectra. 
 
Methyl (R)-2-Benzoyloxyalkanoate: Fraction C from the mixture of 
homologues. CD (MeCN): λmax = 229 (Δε = –3.4) nm. The 
1
H NMR 
spectrum was identical to that reported in the literature.
2
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(2S,3S,4R)-1,3,4-O-Benzoyl-2-benzoylamino-1,3,4-alkanetriol: Fraction D 
from the mixture of homologues. CD (MeCN): λmax = 233 (Δε = –1), 222 
(Δε = +2) nm. The 1H NMR spectrum was identical (apart from the methyl 
region) to that of an authentic sample of D-ribo-phytosphingosine 
perbenzoate.
3
  
 
Oxidative Cleavage and GC-MS Analysis of Sphinganines: Fraction D was 
debenzoylated by acidic methanolysis as described above and subjected to 
oxidative cleavage with KMnO4/NaIO4 as described in the literature.
4
 The 
resulting carboxylic acids were methylated with CH2N2. The esters obtained 
were analyzed by GC-MS, and the results are compiled in Table 2, 
expressed in terms of original sphinganines. 
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Chapter 5 
Planar Structure Elucidation of Terpioside B from 
Terpios sp. 
The investigation of the GSL composition of the marine sponge Terpios 
sp. revealed the presence of terpioside B, a new furanose-rich 
pentaglycosylated glycosphingolipid. Planar structure of terpioside B (1) 
was elucidated using extensive 2D NMR and mass spectrometry studies.  
 
Figure 18: Terpioside B from Terpios sp. 
5.1 Isolation of Terpioside B 
A further analysis of the peracetylated glycolipid fraction obtained from 
Terpios sp. (see Chapter 4) was performed. The extract showed the presence 
of more polar glycosphingoipids and, after repeated HPLC separation on 
SiO2 columns, pure terpioside B peracetate (1b) was obtained.
1a  R = H  
1b  R = CH3CO 
1c  R = CD3CO 
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5.2 Structure Determination 
The ESI mass spectrum of peracetylated terpioside B (1b)  gave a series 
of [M+2Na]
2+
 pseudomolecular ion peaks at m/z 1104.8, 1111.7, 1118.2, 
and 1125.5, in accordance to molecular ions of m/z 2163, 2177, 2191, 2205. 
The singly charged [M+Na]
+
 ions could not be detected, because their m/z 
ratio was beyond the upper limit of the analyzer in the mass spectrometer 
we used. This molecular weights are in accordance with the molecular 
formulas C105H167NO45 + n CH2 (n = 0-3), and showed that terpioside B, like 
most glycolipids of marine origin, is present in Terpios as a mixture of 
homologues. 
 
Figure 19: 
1
H NMR spectrum of terpioside B peracetate in CDCl3 at 700 MHz 
 
 
The general features of the proton spectrum of peracetylated terpioside B 
clearly resembled those of glycolipids, as illustrated by (a) the large band of 
alkyl chain methylene protons at δ 1.24, (b) many overlapping oxymethine 
and oxymethylene protons between δ 3.4 and 5.6 and (c) –NH doublet at δ 
6.65 ppm.   
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All the NMR experiments directed to the structure elucidation were 
performed on the peracetate derivative, to take advantage of the better signal 
dispersion in the proton spectrum of a peracetylated sugar chain and the 
possibility of identifying the glycosylation site of each sugar.  
The ceramide portion of terpioside B is the one most commonly found in 
glycolipids from sponges, and the same as in terpioside A, composed of a 
trihydroxylated, saturated sphinganine and a 2-hydroxy fatty acid.  
 
Figure 20: 2D NMR COSY spectrum of compound 1b in CDCl3 at 700 MHz 
 
Using -NH proton as a starting point, analysis of the 2D COSY allowed 
identification of all the proton of the polar part of the sphinganine up to H-5.  
As for the ceramide fatty acid residue, a resonance at δ 5.13 (H-2VI) in the 
1H NMR spectrum, instead of the characteristic triplet at δ 2.3 of the 
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fattyacid α-protons, indicated the α-hydroxy substitution. This resonance 
showed in the ROESY spectrum an intense correlation peak with the amide 
NH doublet, confirming the –NHCOCHOH– functionality. Both H-2VI and 
2-NH were shown to be coupled with the CO carbon atom at d 170.0 (C-1
VI
) 
by the HMBC spectrum. 
 
 
Figure 21: 2D NMR ROESY spectrum of terpioside B peracetate (1b)  
in CDCl3 at 700 MHz 
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Figure 22: 2D NMR HMBC spectrum of compound 1b in CDCl3 at 700 MHz 
 
Analysis of HSQC spectrum of terpioside B peracetate showed the 
sugar portion of the molecule to be composed by a pentasaccharide chain. In 
the spectrum, resonances for the five anomeric protons (δ 4.41, 4.44, 4.95, 
5.24, and 5.30) and the relevant carbons (δ 100.2, 100.7, 98.8, 100.4, and 
98.7 respectively) were identified.  
Elucidation of the structure of the pentasaccharide chain was more 
challenging for the severe signal overlapping and the presence of two sugars 
in the furanose form. Decisive information came from the z-filtered version 
of the TOCSY 2D NMR experiment. Figure 24 shows sections of the z-
TOCSY experiment displaying subspectra of the six sugar spin-systems, 
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which allowed us to identify the signals of each sugar, starting from the 
relevant anomeric protons.  
 
Figure 23: 2D NMR HSQC spectrum of terpioside B peracetate (1b)  
in CDCl3 at 700 MHz 
 
The first sugar residue of the saccharide chain was identified as a β-
glucopyranoside. The shielded chemical shift of H-5
I
 indicated a pyranose 
ring, while the large coupling constant (7.8 Hz) of the anomeric proton was 
indicative of its axial orientation. The large coupling constants between each 
vicinal pair of ring protons clearly indicated that all the ring proton are 
axial. The HMBC spectrum showed that this sugar is linked to the 
sphinganine (correlation peak between H-1
I
 and C-1), and glycosylated at 4
I
 
(correlation peak between H-1
II
 and C-4
I
). 
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The second sugar residue is a hexopiranose as indicated by the high-field 
chemical shift of H-5
II
. Coupling constants (Table 4) showed that H-1
II
, H-
2
II
 and H-3
II
 are axial, while H-4
II
 is equatorial. This sugar residue is 
therefore a β-galactopyranoside. The shielded chemical shift of H-4II and H-
6
II
 suggested glycosylation at these positions, which was confirmed by the 
HMBC correlation peak between H-4
II
 and C-1
III
 and between H-6
II
 and C-
1
V
. 
The third and last pyranose sugar residue is a α-galactopyranoside. The 
pattern of coupling constants (Table 4) showed the axial orientation of H-
2
III
 and H-3
III
, and the equatorial orientation of H-1
III
 and H-4
III
. As for H-
5
III
, it shows a ROESY correlation peak with H-3
III
, and is therefore axial. 
Finally, this sugar is glycosylated at position 6, as shown by the chemical 
shift of Ha,b -6
III
 (δ 3.60, 3.69) and by the HMBC correlations between H-1IV 
and C-6
III
 and between Ha,b-6
III
 and C-1
IV
. 
The sugar glycosylating the third sugar at position 6 is a 6-
deoxyhexofuranoside, as indicated by the presence of five methine protons 
and the characteristic methyl doublet at δ 1.17 ppm, which pointed the 
presence of a methyl group instead of the usual –CH2OH group at the 6-
position in the relevant spin system. The high-field chemical shift of H-4
IV
 
(δ 3.89), compared with the low-field chemical shift of the H-5IV signal (δ 
4.97), clearly indicated that C-4
IV
 links an oxygen atom involved in an 
acetal function instead of an ester function; thus, the sugar must be in the 
furanose form and not in the more common pyranose form. The low-field 
chemical shifts of H-2
IV
, H-3
IV
, H-5
IV
 and H2-6
IV
 show that hydroxyl groups 
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at positions 2, 3, 5 and 6 are all acetylated, and therefore that the sugar is not 
further glycolsylated.  
The fifth sugar residue, glycosylating the β-galactopyranoside at position 
6 and not further glycosylated, was also a hexose in the furanose form 
(HMBC correlation between H-1
V
 and C-4
V
). Also this sugar is a terminal 
sugar, as argued by the chemical shifts of H-2
V
, H-3
V
, H-5
V
 and H2-6
V
. 
Determination of the stereochemistry of furanose sugars, as well as of the 
absolute configuration of the whole molecule, is still in progress and will be 
performed using methods similar to those described for terpioside A. 
 
Figure 24: The spin systems of the five sugars spectrum of compound 1b 
evidenced by the z-TOCSY spectrum (CDCl3, 700MHz) 
 
 
 
I: β-Glucopyranose 
II: β-Galactopyranose 
III: α-Galactopyranose 
IV: 6-deoxyhexofuranose 
 V: 6-deoxyhexofuranose  
Sphinganine  
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5.3 Experimental Section 
Collection, extraction and isolation: Specimens of Terpios were treated as 
previous described for terpioside A (Chapter 4). The sponge homogenized 
was extracted with methanol and chloroform; the combined extracts were 
partitioned between H2O and n-BuOH. The organic layer was purified by 
subsequent chromatography on RP-18 silica gel column and SiO2. This 
procedure allowed to obtain a fraction mainly composed of glycolipids. This 
fraction was peracetylated with Ac2O in pyridine for 12 h. The acetylated 
glycolipids were subjected to HPLC separation on an SiO2 column [eluent: 
n-hexane/EtOAc (6:4)], thus affording a fraction which was further 
chromatographed with HPLC on a SiO2 column [eluent: n-hexane/iso-PrOH 
(8:2)] affording to 7 mg of pure terpioside peracetate (1b). 
 
Terpioside B peracetate (1b): The peracetylated derivative 1b was obtained 
as colorless oil. 
1
H- and 
13
C-NMR are reported in Table 4. 
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Table 4: 
1
H and 
13
C NMR data of terpioside B peracetate (1b) 
Position  H  (mult, J (Hz))
 C (mult)   
1 a 3.85
a
 66.6 (CH2) 
 b 3.57 (dd, 10.8, 3.5)  
2  4.28 (m) 47.8 (CH) 
2-NH  6.65 (d, 8.9)  
3  5.1 (dd, 8.3, 2.5) 71.3 (CH) 
4  4.86 (dt, 10.0, 2.9, 2.9) 73.0 (CH) 
5 a, b 1.58
a
 28.0 (CH2) 
1'  4.41 (d, 7.8) 100.2 (CH) 
2'  4.80 (dd, 9.5, 7.8) 71.1 (CH) 
3'  5.1 (t, 9.5) 72.1 (CH) 
4
'  
3.84 (t, 9.5) 75.5 (CH) 
5'  3.58
a
 72.7 (CH) 
6' a 4.48 (dd, 12.1, 1.7) 61.9 (CH2) 
 b 4.10 (dd, 12.1, 5.5)  
1''  4.44 (d, 8.1) 100.7 (CH) 
2''  5.03 (dd, 10.7, 8.1) 68.8 (CH) 
3''  4.74 (dd, 10.7, 2.6) 72.8 (CH) 
4''  4.01 (br. d, 2.6)  77.0 (CH) 
5''  3.64 (m) 73.9 (CH) 
6'' a 3.78 (dd, 11.6, 4.3) 65.9 (CH2) 
 b 3.73 (dd, 11.6, 6.5)  
1'''  4.95 (d, 3.3) 98.8 (CH) 
2'''  5.15 (dd, 11.1, 3.3) 68.7 (CH) 
3'''  5.30 (dd, 11.1, 1.8) 67.2  (CH) 
4'''  5.58 (br. d, 3.2) 67.7 (CH) 
5'''  4.29 (m) 66.9 (CH) 
6''' a 3.60 (dd, 10.4, 5.5) 64.4 (CH2) 
 b 3.69 (br. t, 10.4)  
1
IV
  5.24 (d, 4.5)  100.4 (CH) 
2
IV
  5.15 (dd, 6.7, 4.5) 75.9 (CH) 
3
IV
  5.45 (t, 6.7) 74.2 (CH) 
4
IV
  3.89 (t, 6.7) 81.2 (CH) 
5
IV
  4.97 (t, 6.4) 71.0 (CH) 
6
IV
  1.17 (d, 6.4) 15.3 (CH3) 
1
V
  5.30 (d, 4.6) 98.7 (CH) 
2
V
  4.95 (dd, 6.9, 4.6) 76.8 (CH) 
3
V
  5.54 (t, 6.9) 73.5 (CH) 
4
V
  3.87 (t, 6.9) 80.7 (CH) 
5
V
  5.02 (t, 6.9) 70.2 (CH) 
6
V
  1.19 (d, 6.5)  15.6 (CH3) 
1
VI
 CO  169.7 
2
VI
  5.13
a
 73.8 (CH) 
3
VI
 a, b 1.83 (m) 31.6 (CH2) 
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Ac's 
CH3  
CO 
2.22 – 1.96 
– 
20.1 – 20.3  
169.8 – 170.2 
 
a. Overlapped signals 
b. Additional 1H signals: δ = 1.24 (br., alkyl chain protons), 0.88 (t, J = 
7.0 Hz, n-chain Me groups), 0.86 (d, J = 6.7 Hz, iso-chain Me 
groups) ppm.  
c. Additional 13C signals: δ = 29.4 (CH2, ω-2), 22.7 (CH2, ω-1), 22.7 
(CH3, iso-chain Me groups), 14.1 (CH3, ω) ppm
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Chapter 6 
Amphiceramides A and B from the Sponge 
Amphimedon compressa 
Chemical analysis of the Caribbean sponge Amphimedon compressa 
showed it to contain two novel glycosphingolipids, amphiceramide A (1) 
and B (2), possessing an unusual Δ6-phytosphingosine. The saccharide chain 
of amphiceramide A is composed of a β-glucose residue glycosylated at 
position 6 by an N-acetyl-β-glucosamine. This diglycoside has never been 
found before in a natural product. The saccharide chain of amphiceramide B 
consists of an allolactose [Gal(1β    6)Glc] residue β-linked to the ceramide. 
In addition, the sponge contains a new molecular species of 
acetamidoglucosyl ceramide (3), and the known glucosyl ceramide 4 
(halicerebroside A)
1
 and melibiosyl ceramide 5 (amphimelibioside C).
2
  The 
elucidation of the stereostructure of amphiceramides has been accomplished 
by a combination of extensive one- and two-dimensional NMR 
spectroscopy, MS and MS/MS spectrometry, and chemical degradation.
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Figure 25: Glycosphingolipids from Amphimedon compressa 
                                                                                                      Chapter 6 
  
69 
 
6.1 Isolation of Amphiceramides 
Following our usual procedure, the BuOH soluble fraction obtained 
from the combined chloroform and methanol extracts of A. compressa was 
subjected first to reversed-phase and then to normal-phase silica gel column 
chromatography, to get a fraction mainly composed of glycolipids. The 
fraction was acetylated with Ac2O in pyridine to give a peracetylated 
fraction, which is easier to purify by HPLC on a SiO2 column. The HPLC 
separation yielded five peracetylated glycolipids, each isolated as a mixture 
of homologues. Unlike what we have observed in other sponges, these 
mixtures were relatively simple, with one single major homologue in each 
fraction, as judged by the respective MS and 
1
H NMR spectra. Therefore, 
the five glycolipid mixtures were subjected to reversed-phase HPLC 
separation, which yielded the five pure peracetylated glycolipids 1b-5b.  
As for terpioside A, to distinguish any acetyl group possibly present in 
the natural glycolipid from those introduced during the acetylation reaction, 
the isolation procedure was repeated using deuterated acetic anhydride in 
the acetylation step, giving the pertrideuteroacetylated derivatives 1c-5c. 
The 
1
H NMR spectra of compounds 2c, 4c, and 5c were identical to those of 
the respective peracetylated derivatives, except that no acetyl methyl singlet 
was present in the spectrum. This showed that all the acetyl groups came 
from the acetylation reaction. The 
1
H NMR spectrum of compound 1c 
showed one acetyl methyl singlet, indicating that one acetyl group is present 
in the natural compound 1a. The subsequent structure elucidation work 
showed that this acetyl group is part of an amide function. Likewise, the 
1
H 
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NMR spectrum of compound 3c also contained one acetyl signal, showing 
that the natural compound 3a contains an acetamido group. Finally, the 
peracetylated glycolipids were deacetylated using MeONa/MeOH (the 
acetamido groups present in compounds 1a and 3a survive these reaction 
conditions) to give the respective natural glycolipids 1a-5a.  
6.2 Structure Determination of Amphiceramide A 
The positive-ion ESI mass spectrum of amphiceramide A (1a) showed a 
sodiated pseudomolecular ion peak at m/z 1041, in accordance with the 
molecular formula C72H120N2NaO24
+
. This was confirmed by a high-
resolution measurement at m/z 1041.7172. The ESI mass spectrum of the 
peracetyl derivative 1b showed an [M + Na]
+
 pseudomolecular ion peak at 
m/z 1419, indicating the presence of 9 additional acetyl groups. Compound 
1b was used for the subsequent NMR analysis.  
The general 
1
H NMR spectral features of compound 1b showed it to be 
a glycosphingolipid: the NH doublet at δ = 6.94 of the ceramide amide 
function, a series of overlapped signals in the region between δ 5.4 and 3.4, 
nine signals of acetyl groups around δ 2.0, an intense signal at δ 1.24 
indicative of a long aliphatic chain, and 6H methyl triplet at δ 0.88 as the 
sole signal in the high-field region of the spectrum, indicating that the alkyl 
chains of the ceramide were both unbranched. A second amide NH doublet 
at δ 6.48 suggested the presence of an aminosugar in the molecule.
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Figure 26: 
1
H NMR spectrum of amphiceramide A (1b) in CDCl3 at 700MHz 
 
The absence of the characteristic triplet of the fatty acid α-protons at δ 
2.3 suggested the presence in the ceramide moiety of an α-hydroxy acid, as 
usually found in GSLs from marine sponges. In addition, the presence of 
two methine groups resonating at δ 134.9 and 123.7 evinced from the 13C 
NMR and HSQC spectra indicated a disubstituted double bond.  Starting 
from the NH doublet at δ 6.94 (2-H), the COSY spectrum allowed 
sequential assignment of all the protons of the sphingosine. In particular, the 
scalar coupling of the two diastereotopic methylene protons at δ 2.37 and 
2.24 (5-H2) with the oxymethine proton at δ 4.94 (4-H) and the olefinic 
proton at δ 5.24 (6-H), located the double bond on the sphingosine at 
position 6. In addition, the coupling constant between 6-H and 7-H (15.2 
Hz) indicated the E stereochemistry of the double bond. The HMBC 
correlation of coupling of 2-H with C-1
III
 (δ 170.2) and C-2 (δ 48.9) 
confirmed the amide linkage between the sphingosine and the fatty acid. 
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Figure 27: 2D NMR COSY spectrum of amphiceramide A (1b) 
 in CDCl3 at 500MHz 
 
The key step in structural elucidation of a GSL is the identification of 
the nature of the sugars composing the saccharide chain. This can be 
achieved collecting data from COSY, TOCSY and HSQC to identify the 
spin system of each sugar unit and to assign the protons within each spin 
system. If the sugars are in the pyranose form, the nature of each sugar can 
then be easily identified by coupling constants analysis. Finally, 
identification of the positions involved in the sugar-ceramide and in the 
sugar-sugar linkages is based on HMBC and/or ROESY data.   
Following this protocol, the two anomeric protons (δ 4.61 and 4.46) 
were identified from their HMQC correlation peaks with the respective 
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anomeric carbons signals, resonating at δ 101.4 and 100.1 in the 13C NMR 
spectrum. 
 
 Figure 28: 2D NMR HSQC spectrum of amphiceramide A (1b)  
in CDCl3 at 700MHz 
 
Then, starting from each anomeric proton resonance, each sugar spin 
system was assigned using the TOCSY and COSY spectra. Both sugar 
residues contain, in addition to the anomeric CH, four methine and one 
methylene groups, and are therefore hexoses. The upfield chemical shift of 
5
I
-H and 5
II
-H showed that the respective oxymethine groups are not 
involved in an ester function, indicating that the two sugar residues are both 
in the pyranose form. Coupling constant analysis allowed to establish that 
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all the ring protons of the sugar with the anomeric proton at δ 4.46 are axial, 
and therefore that this sugar residue is a β-glucopyranoside. 
 
Figure 29: The spin systems of the two sugars spectrum of compound 1b 
evidenced by the z-TOCSY spectrum (CDCl3, 500MHz) 
 
 
As for the second unit, the chemical shift values of C-2
II
 (δ 54.2) and 
2
II
-H (δ 3.95) were indicative of an N-linked methine carbon, and this was 
confirmed by the coupling of 2
II
-H with the NH doublet at δ 6.48. Coupling 
constant analysis showed that also for this sugar the ring protons are all 
axial, and therefore the sugar residue was identified as a 2-amino-2-
deoxyglucopyranoside. Finally, the HMBC correlation peak of 1
I
-H with C-
1 showed that the glucose was directly linked to ceramide, while that of 1
II
-
H with C-6
I
 showed that the glucosamine is glycosylating the glucose at 
position 6
I
. Once the gross structure of the peracetyl derivative 1b was 
elucidated, NMR spectra of 1a were collected and fully assigned, providing 
further support to the proposed structure (Experimental Part). 
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Figure 30: 2D HMBC spectrum of amphiceramide A (1b) 
in CDCl3 at 700MHz 
 
The absolute configuration of the two sugars, the configuration at C-2
III
 of 
the α-hydroxy fatty acid, and the configuration at C-2, C-3 and C-4 of the 
sphingosine were determined by chemical degradation. We used a 
simplified version of the micro-scale procedure we have developed for the 
analysis of glycolipids isolated as mixtures of homologues.
3
 Compound 1a 
was subjected to acidic methanolysis, and the reaction products were 
perbenzoylated and subjected to HPLC, giving compounds 6–9. The methyl 
glycoside 6 was identified as methyl tetra-O-benzoyl-α-D-glucopyranoside 
by comparison of its 
1
H NMR and CD spectra with those reported in the 
literature.
4
 The methyl glycoside 7 was identified as methyl tri-O-benzoyl-
2-benzamido-2-deoxy-α-D-glucopyranoside by comparison of its 1H NMR 
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and CD spectra with those of an authentic sample prepared from N-acetyl-D-
glucosamine with the same procedure used for compound 1a. The fatty ester 
8 was identified as methyl (R)-2-benzoyloxydocosanoate from the EI mass 
spectrum (M
+
 at m/z 474) and from the 
1
H NMR and CD spectra, which 
matched those reported. The stereochemistry of the perbenzoylated Δ6-
phytosphingosine 9 could not be determined directly from its spectra 
because reference data were not available in the literature.  
           
Scheme 2: Microscale degradation analysis of Amphiceramide A (1a) 
 
In the 
1
H- NMR spectrum of 9, chemical shifts and coupling constant of 
protons at C-1 through C-4 were close to those of d-ribo-phytosphingosine 
perbenzoate (10), but the presence of the additional double bond 
significantly affected the CD spectrum of 9, which was remarkably different 
from that of the reference compound, and did not allow a reliable 
assignment of its configuration. Therefore, compound 1a was subjected to 
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catalytic reduction with H2/PtO2, and the reaction product was subjected to 
the degradation procedure described above. HPLC separation gave a 
compound whose 
1
H-NMR and CD spectra were identical to those of ribo-
phytosphingosine perbenzoate 10, thus defining also the configuration of the 
the perbenzoylated Δ6-phytosphingosine 9.  
Structure 1a was further supported by an MS/MS spectrum, carried out by 
dissolving the sample in MeOH with 1 mM LiCl as previously reported and 
using the [M + Li]
+
 pseudomolecular ion at m/z 1025 as the precursor ion. 
The spectrum contained three peaks at m/z 660 and 687 and 822 arising 
from, respectively, the loss of the dehydrated whole saccharide chain, the 
loss of a C22 2-hydoxyacyl group and the loss of the dehydrated N-
acetylglucosamine.  
 
 
 
Figure 31: MS/MS fragmentation pathways of the lithiated adduct of (1a) 
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Table 5: 
1
H and 
13
C NMR spectroscopic data of  amphiceramide A 1b (CDCl3) 
 
 
 
 
a O
v
e
r
l
a
p
p
e
d
 
s
i
g
n
a
l
s 
 
 
 
 
 
 
 
  
Position  δH (mult., J [Hz]) δC (mult.) 
1 a 3.80  (dd, 10.9,  4.0) 65.8 (CH2) 
 b 3.69  (dd, 10.9, 4.2)  
2  4.28
a
 48.9 (CH) 
2-NH  6.94 (d, 8.4) - 
3  5.04 (dd, 6.2, 4.9) 72.5 (CH) 
4  4.94 (ddd, 8.9, 4.9, 3.5) 72.4 (CH) 
5 a 2.37 (m) 32.7 (CH2) 
 b 2.24
a
  
6  5.24 (ddd, 15.2, 6.9, 6.9) 123.7 (CH) 
7  5.48 (ddd, 15.2, 6.8, 6.8) 134.9 (CH) 
8  1.96
a
 32.6 (CH2) 
9-15, 4'''-19'''  1.24
a
 29.7 (CH2) 
16, 20'''  1.25
a
 31.9 (CH2) 
17, 21'''  1.28
a
 22.7 (CH2) 
18, 22'''  0.88 (t, 6.8) 14.1 (CH3) 
1'  4.46
 
(d, 8.0)
 
 100.1 (CH) 
2'  4.85 (dd, 9.6, 8.0) 71.2 (CH) 
3'  5.18  (t, 9.5) 72.8 (CH) 
4'  4.98 (dd, 10.0, 9.5) 68.5 (CH) 
5'  3.65 (ddd, 10.0, 5.5, 1.7)  73.6 (CH) 
6' a 3.95
a 
67.6 (CH2) 
 b 3.52
 
(dd, 11.9, 5.5)  
1''  4.61 (d, 8.4 ) 101.4 (CH) 
2''  3.95
a 
54.2 (CH) 
2''-NH  6.48 (d, 8.9) - 
2''-Ac  1.95 23.1 (CH3) 
  - 170.7 (C) 
3''  5.24  (dd, 10.5, 9.4) 72.7 (CH) 
4''  5.06  (dd, 10.0, 9.4) 68.7 (CH) 
5''  3.70
a
 71.8 (CH) 
6'' a 4.28 (dd, 12.3, 4.7) 62.1 (CH2) 
 b 4.10 (dd, 12.3, 2.3)  
1'''  -
 
170.2 (C) 
2'''  5.11 (dd, 7.5, 4.6)
 
74.1 (CH) 
3'''  1.84 (m) 31.7 (CH2) 
Ac's  2.22, 2.10, 2.09, 2.06, 2.04, 
2.03, 2.02, 2.01, 1.98 
21.1-20.6 (CH3) 
  - 171.1–169.3 (C) 
a. Overlapped signals 
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6.3 Structure Determination of Amphiceramide B 
Compound 2a showed a [M + Na]
+
 pseudomolecular ion peak in the 
high resolution ESI mass spectrum at m/z 1000.6907, in accordance with the 
molecular formula C53H101NO14. The 
1
H NMR spectrum of the peracetate 
2b was similar to that of 1b, but only one NH doublet was present. This data 
suggested a diglycosylceramide with no aminosugar present in the structure. 
The ceramide part of the molecule appeared the same as that of 1b, each 
proton showing chemical shift close to those observed in 1b, and nearly 
identical coupling constants.  
The structure of the saccharide chain of 2b was studied with the same 
methods used for 1b. The sugar linked to the ceramide is, again, a β-
glucopyranoside, glycosylated at position 6
I
 by the second sugar, which was 
shown to be a β-galactopyranoside on the basis of the following evidence. 
The 2
II
-H proton showed a large coupling with both 1
II
-H and 3
II
-H, and 
these three protons are therefore axial. In contrast, the coupling constant 
between 3
II
-H and 4
II
-H (3.4 Hz) showed the latter proton to be equatorial. 
As for 5
II
-H, its axial orientation was demonstrated by its intense correlation 
peak with the axial 3
II
-H in the ROESY spectrum. 
The absolute configuration of the sugar was determined with the same 
degradation scheme described for 1a (Scheme 2). In this case, however, the 
benzoylated α-glycosides of glucose and galactose (which are the major 
products of the reaction sequence) coeluted from the HPLC column, and 
could not be obtained in the pure form. The corresponding β-glycosides 11 
and 12, although less abundant, gave rise to distinct peaks in the 
chromatogram. Structure and absolute configuration of compounds 11 and 
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12 were identified by comparison of their 
1
H NMR and CD spectra with 
those reported in the literature.
5
  
         
Scheme 3: Microscale degradation analysis of Amphiceramide B (2a) 
Finally, the structure of the ceramide of 2a, and in particular the 
length of the two alkyl chains, was confirmed by MS/MS spectrometry. The 
[M + Li]
+
 pseudomolecular ion of 2a at m/z 984 showed the same 
fragmentation pattern (Figure 32), with the loss of a C22 α-hydroxy acyl 
group leading to the the fragment ion at m/z 646. 
 
 
 
Figure 32: MS/MS fragmentation pathways of the lithiated adduct of (2a) 
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Table 6: 
1
H and 
13
C NMR spectroscopic data of  amphiceramide B 2b (CDCl3) 
 
Position  δH (mult., J [Hz]) δC (mult.) 
1 a 3.90
a
 66.9 (CH2) 
 b 3.61
a
  
2  4.32 (m)
 
48.4 (CH) 
2-NH  6.88 (d, 8.9) - 
3  5.09 (dd, 7.3, 4.1) 72.1 (CH) 
4  4.91  (ddd, 9.3, 4.1, 3.6) 72.6 (CH) 
5 a 2.36 (m) 32.3 (CH2) 
 b 2.24
a
  
6  5.26 (ddd, 15.2, 6.7, 6.7) 124.1 (CH) 
7  5.47 (ddd, 15.2, 6.8, 6.8) 134.8 (CH) 
8  1.95 (m)  32.7 (CH2) 
9-15, 4'''-19'''  1.24
a
 29.8 (CH2) 
16, 20'''  1.24
a
 32.0 (CH2) 
17, 21'''  1.28
a
 22.8 (CH2) 
18, 22'''  0.88 (t, 6.8) 14.2 (CH2) 
1'  4.44
 
(d, 8.0)
 
 100.6 (CH) 
2'  4.84 (dd, 9.7, 8.0) 71.5 (CH) 
3'  5.15 (t, 9.6) 72.9 (CH) 
4'  4.93 (t, 9.9, 9.5) 69.0 (CH) 
5'  3.64 (m) 73.4 (CH) 
6' a 3.88 (dd, 11.2, 1.7)
 
68.0 (CH2) 
 b 3.60
a 
 
1''  4.52 (d, 8.0) 101.3 (CH) 
2''  5.17 (t, 10.5, 8.0)
 
68.8 (CH) 
2''-NH  - - 
2''-Ac  - - 
  - - 
3''  5.04  (dd, 10.5, 3.4) 71.0 (CH) 
4''  5.38  (dd, 3.4, 1.2) 67.2 (CH) 
5''  3.92 (ddd, 6.7, 6.7, 1.2) 70.8 (CH) 
6'' a 4.20 (dd, 11.3, 6.5) 61.3 (CH2) 
 b 4.10 (dd, 11.3, 6.9)  
1'''  -  169.8 (C) 
2'''  5.13 (dd, 7.3, 4.8)
 
74.1 (CH) 
3'''  1.84
a
 31.9 (CH2) 
Ac's  2.22, 2.15, 2.09, 2.07, 2.06, 
2.04, 2.04, 2.02, 1.98, 1.98 
21.1-20-7 (CH3) 
  - 170.7-169.3 
 
a. Overlapped signal 
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Figure 33: 
1
H NMR spectrum of amphiceramide B peracetate (2b) 
in CDCl3 at 700MHz 
 
 
     
 
Figure 34: 2D NMR COSY spectrum of  2b in CDCl3 at 700MHz 
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Figure 35: Middle-field 2D NMR COSY spectrum of peracetylated  
 amphiceramide B in CDCl3 at 700MHz 
 
 
 
 
 
Figure 36: Spin systems in the Z – TOCSY spectrum of compound 2b in 
CDCl3 at 700MHz 
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Figure 37a, b: 2D NMR HSQC spectra of 2b in CDCl3 at 700MHz and 
500MHz 
 
 
 
 
a) 
b) 
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 Figure 38 a,b: 2D NMR ROESY spectra of 2b in CDCl3 at 700MHz 
 
a) 
b) 
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Figure 39 a,b: 2D NMR HMBC spectra of 2b in CDCl3 at 700MHz 
a) 
b) 
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6.4 Structure Determination of 3a, 4a, and 5a 
The 
1
H and 
13
C NMR data of the peracetate 3b were very similar to 
those reported for amphicerebroside B heptaacetate, a monoglycosyl 
ceramide composed of a Δ6-unsaturated phytosphingosine and an N-acetyl-
β-glucosamine. The only difference between the two compounds, the 
unbranched C18 sphingosine of 3b instead of the iso C19 sphingosine of 
amphicerebrosiede B, was reflected in the 6H methyl triplet at δ 0.88 in the 
1
H NMR spectrum of 3b.  This was confirmed by the mass spectrum of the 
natural compound 3a, showing a lithiated [M + Li]
+
 pseudomolecular ion at 
m/z 863 indicative of a C40 ceramide. The fragment ion at m/z 525 in the 
MS/MS spectrum ([M + Li – C22H42O]
+
) indicated a C22 α-hydroxy fatty 
acid and, consequently, a C18 sphingosine. 
The ESI mass spectrum of compound 4a ([M + Na]
+
 at m/z  838) 
was consistent with the molecular formula C46H89NO10 and indicative of a 
monohexosylceramide with the same ceramide of compounds 1a and 2a. 
Examination of the 
1
H NMR spectrum of the peracetate 4b evidenced the 
presence of the signals of a β-glucopyranoside (chemical shift and coupling 
constants matched well those reported for a β-glucosylceramide peracetate), 
while the signals of the ceramide proton were very similar to those of 1b 
and 2b. Degradation analysis as described above lead to the formation of the 
methyl glycoside 6, the fatty ester 8, and the sphingosine 9, thus defining 
completely structure 4a. Compound 4a had been previously reported as 
halicerebroside A from the Red Sea sponge Halilona sp, but due to the 
limited spectroscopic data present in the original paper identification by 
spectral comparison was not possible. 
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Finally, compound 5a was identified by comparison of its MS, 
1
H 
NMR, and 
13
C NMR data with those reported for amphimelibioside C from 
the Japanese sponge Amphimedon sp.  
6.5 Experimental Section 
Collection, Extraction, and Isolation Procedures: Specimens of 
Amphimedon compressa were collected in the summer of 2005 along the 
coast of Key Largo (Florida). They were frozen immediately after collection 
and kept frozen until extraction. The sponge (290 g of dry weight after 
extraction) was homogenized and extracted with methanol (3·x 5 L) and 
then with chloroform (3· 5 L); the combined extracts were partitioned 
between H2O and n-BuOH. The organic layer was concentrated in vacuo 
and afforded 53.3 g of a dark oil, which was chromatographed on a column 
packed with RP-18 silica gel. A fraction eluted with CHCl3 (4.7 g) was 
further chromatographed on a SiO2 column, giving a fraction [1.01 g, 
eluent: EtOAc/MeOH (7:3)] mainly composed of glycolipids. This fraction 
was peracetylated with Ac2O in pyridine for 12 h. The acetylated 
glycolipids were subjected to HPLC separation on an SiO2 column [eluent: 
n-hexane/EtOAc (6:4)]. Five major fractions were obtained, each mainly 
composed of one of compounds 1b-5b. Amphiceramide A (5.6 mg) and 4 
Amphiceramide B (1.6 mg), were obtained in the pure form from the 
respective fractions after a further normal phase HPLC purification [eluent: 
n-hexane/i-PrOH (85:15)] followed by reversed-phase HPLC using MeOH 
as eluent. 
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Amphiceramide A peracetate (1b): Amorphous solid [α]25D= +2 (c = 1.5, 
CHCl3); ESIMS (positive ion mode, MeOH) m/z 1419 ([M + Na]
+
). 
1
H and 
13
C NMR: see Table 5. 
 
Amphiceramide B peracetate (2b): Amorphous solid. [α]25D= +4 (c 0.5, 
CHCl3); ESIMS (positive ion mode, MeOH) m/z 1420 ([M + Na]
+
). 
1
H and 
13
C NMR: see Table 6. 
 
Compound (3b): Amorphous solid. ESIMS (positive ion mode, MeOH) m/z 
1131 ([M + Na]
+
). 
1
H NMR (CDCl3) δ = 0.88 (n-chain Me groups), 1.28 
(large band, alkyl chains), 1.94 (s, 3 H, Ac), 1.95 (overlapped, 2 H, 8-Ha, 8-
Hb), 2.00-2.07 (several protons acetyl Me groups), 1.94 (s, 3 H, NH-Ac), 
2.23 (overlapped, 1 H, 5-Hb), 2.34 (m, 1 H, 5-Ha), 3.48 (m, 1 H, 2'-H), 3.74 
(overlapped, 2H, 1-Ha, 1-Hb), 3.74 (overlapped, 1 H, 5'-H), 4.10 (br. d, J = 
12.4 Hz, 1 H, 6'-Hb), 4.24 (dd, J = 12.4, 4.1 Hz, 1 H, 6'-Ha), 4.30 (m, 1 H, 2-
H), 4.85 (d, J = 8.2 Hz, 1 H, 1'-H), 4.95 (overlapped, 1 H, 3-H), 4.95 
(overlapped, 1 H, 4-H), 5.00 (t, J = 9.6 Hz, 1 H, 4'-H), 5.07 (dd, J  = 4.5, 
7.3Hz, 1 H, 2''-H), 5.23 (ddd, J = 6.9, 15.2, 6.9 Hz, 1 H, 6-H), 5.37 (t, J  = 
9.6 Hz, 1 H, 3'-H), 5.44 (ddd, J = 6.6, 15.2, 6.6 Hz, 1 H, 7-H), 6.07 (br. s, 
1H, 2'-NH), 7.1 (d, J = 8.6 Hz, 1H, 2-NH) 
13
C NMR (CDCl3) δ = 14.2 (CH3, 
18-C, 22''-C), 20.5-23.2 (several CH3, acetyl Me groups), 22.7-31.8 (several 
CH2, alkyl chain), 32.7 (CH2, 5-C), 32.7 (CH2, 8-C), 47.8 (CH, 2-C), 55.5 
(CH, 2'-C), 61.9 (CH2, 6'-C), 66.2 (CH2, 1-C), 68.8 (CH, 4'-C), 71.9 (CH, 5'-
C), 72.2 (CH, 3'-C), 72.6 (CH, 4-C), 72.6 (CH, 3-C), 98.9  (CH, 1'-C), 123.7 
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(CH, 6-C), 134.7 (CH, 7-C), 170.1  (CO, 1''-C), 171.2 (CO, NH-Ac) 177.1-
169.6 (several C, acetyl CO groups). 
 
Deacetilation of compounds 1b-4b: Compound 1b, 2b, 3b and 4b were 
dissolved in MeOH (1 mL) and a solution of solution of MeONa in MeOH 
(0.4 M, 50 μL) was added. The reactions were allowed to proceed at 25 °C 
for 18 h and then the reaction mixtures were dried under nitrogen and the 
residues partitioned between water and chloroform. After removal of the 
solvent, the organic layers gave the native glycosphingolipids (1a, 1.5 mg; 
2a, 0.9 mg; 3a, 11.3 mg; 4a, 2.8 mg).  
 
Amphiceramide A (1a): Colorless solid [α]25D= -4 (c 0.9, CHCl3); HR-MS 
(ESI positive ion mode, MeOH) calcd. for [C54H102N2NaO15]
+
  1041.71724. 
1
H and 
13
C NMR: see Table 7. 
 
Amphiceramide B (2a): Colorless solid [α]25D= -7 (c 0.5, CHCl3); HR-MS 
(ESI positive ion mode, MeOH) calcd. for [C52H99NNaO15]
+
  1000.69069. 
1
H and 
13
C NMR: see Table 8. 
 
Compound 3a: White solid; HR-MS (ESI positive ion mode, MeOH) calcd. 
for [C48H92N2NaO10]
+
 879.66442. 
1
H NMR (C5D5N) δ = 0.86 (t, J = 6.84 
Hz, 3H, 18-H, 22''-H), 1.27 (overlapped, 2H, 9-H, 15-H), 1.27 (overlapped, 
2H, 16-H, 20''-H), 1.27 (overlapped, 2-H, 17-H, 21''-H), 1.97 (overlapped, 
1H, 3''-Ha), 2.02 (overlapped, 2H, 8-H), 2.18 (overlapped, 1H, 3''-Hb), 2.18 
(overlapped, 3H, NH-Ac), 2.67 (multiplet, 1H, 5-Hb), 3.00 (multiplet, 1H, 5-
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Ha), 3.82 (multiplet, 1H, 5'-H), 4.18 (t, J = 9.2 Hz, 1H, 4'-H), 4.23 
(overlapped, 1H, 4-H), 4.24 (t, J = 9.2 Hz, 1H, 3'-H), 4.29 (overlapped, 1H, 
6'-Hb), 4.29 (overlapped, 1H, 3-H), 4.44 (overlapped, 1H, 6'-Ha), 4.48 
(multiplet, 1H, 2'-H), 4.54 (dd, J = 10.9, 3.9, 1H, 1-Hb), 4.59 (overlapped, 
1H, 1-Ha), 4.59 (overlapped, 1H, 2''-H), 5.12 (d, J = 8.3, 1H, 1'-H), 5.24 
(multiplet, 1H, 2-H), 5.70 (ddd, J = 15.2, 6.6 Hz, 1H, 7-H), 5.94 (ddd, J = 
15.2, 6.8 Hz, 1H, 6-H), 8.5 (d, J = 9.3, 1H, 2'-NH), 8.85 (d, J = 7.7, 1H, 2-
NH): 
13
C NMR (C5D5N) δ = 14.0 (CH3, 18-C, 22''-C), 22.8 (CH2, 17-C, 21''-
C), 23.2 (CH3, NH-Ac), 29.7 (CH2, 9-C, 15-C), 32.9 (CH2, 8-C), 35.2 (CH2, 
3''-Ca, b), 36.7 (CH2, 16-C, 20''-C),  37.4 (CH2, 5-Ca, b), 50.4 (CH, 2-C), 57.5 
(CH, 2'-C), 62.2 (CH2, 6'-Ca, b), 68.6 (CH2, 1-Ca, b), 72 (CH,  4'-C), 72.2 
(CH, 2''-C), 72.5 (CH, 3'-C), 75.1 (CH, 3-C), 76.7 (CH, 4-C), 78.2 (CH, 5'-
C), 101.7 (CH, 1'-C), 127.8 (CH, 6-C), 132.6 (CH, 7-C), 172.2 (CO, NH-
Ac), 175.7 (C, 1''-C). 
 
Methanolysis of Amphiceramide A (1b): Compound 1b (1.2 mg) was 
dissolved in 1N HCl in 91% MeOH (500 μL), and the solution obtained was 
kept at 80 °C for about 12 h. The reaction mixture was dried under nitrogen 
and benzoylated with benzoyl chloride (50µL) in pyridine (500µL) at 25
o
 C 
for 16h. The reaction was then quenched with MeOH; after 30 min, the 
mixture was dried under nitrogen. Methyl benzoate was removed by 
keeping the residue under vacuum with an oil pump for 24 h. The residue 
was purified by HPLC [column: Luna SiO2, 5 μ; eluent: n-hexane/iPrOH 
(99:1); flow: 1 mL min
–1
]. The chromatogram showed four peaks: methyl 
glycoside 6, identified as methyl tetra-O-benzoyl-α-D-glucopyranoside (tR = 
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10.8 min) by comparison of its 
1
H NMR and CD spectra with those reported 
in the literature, methyl tri-O-benzoyl-2-benzamido-2-deoxy-α-
glucopyranoside 7 (tR = 43.3 min) identified by comparison of its 
1
H NMR 
and CD spectra with those of an authentic sample, the benzoylated fatty acid 
methyl ester (8, tR = 4.0 min), recognized as methyl (R)-2-
benzoyloxydocosanoate because of its EI mass, 
1
H NMR and CD spectra, 
corresponding to those reported, the perbenzoylated Δ6-phytosphingosine 
(9, tR = 10.5 min). 
 
(2S,3S,4R)-1,3,4-O-Benzoyl-2-benzoylaminooctadec-6-ene-1,3,4-triol (9): 
1
H-NMR (CDCl3): δ = 0.87 (d, J = 6.9 Hz, 3H, 18-H3), 1.34-1.16 (large 
band, alkyl chain), 1.88 (m, 2H, 8-H2), 2.62 (m, 1H, 5-Hb), 2.74 (m, 1H, 5-
Ha), 4.59 (dd, J = 12.0 and 6.1 Hz, 1H, 1-Hb), 4.67 (dd, J = 12.0 and 6.0 Hz, 
1H, 1-Ha), 5.15 (m, 1H, 2-H), 5.41 (ddd, J = 15.2, 7.2, and 7.2 Hz, 1H, 6-H 
or 7-H), 5.52 (ddd, J = 15.2, 7.0, and 7.0 Hz, 1H, 7-H or 6-H), 5.56 (m, 1-H, 
H-4), 5.72 (t, J = 5.2 Hz, 1H, 3-H), 7.14 (1H, d, J = 9.1 Hz, NH-2), 7.33-
7.63 (12 H, overlapping signals, benzoyl protons), 7.83 (2H, d, J = 7.7 Hz, 
benzoyl ortho protons), 7.93 (2H, d, J = 7.7 Hz, benzoyl ortho protons), 8.01 
(2H, d, J = 7.7 Hz, benzoyl ortho protons), 8.04 (2H, d, J = 7.7 Hz, benzoyl 
ortho protons);  CD (MeCN): λmax (Δε)= 250 nm (–2), 222 nm (+8). 
 
Methyl tri-O-benzoyl-2-benzamido-2-deoxy-α-glucopyranoside (7): N-
acetyl-d-glucosamine (11.2 mg) was subjected to acidic methanolysis as 
described above. The resulting methyl glycosides were benzoylated with 
benzoyl chloride (200 μL) in pyridine (2 mL) at 25 °C for 16 h. The reaction 
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was quenched with MeOH; after 30 min, the mixture was dried under 
nitrogen. Methyl benzoate was removed by keeping the residue under 
vacuum with an oil pump for 24 h. The residue was purified by HPLC 
[column: Luna SiO2, 5 μ; eluent: n-hexane/iPrOH (99:1); flow: 1 mLmin
–1
; 
UV detector: 260 nm] and afforded the glycoside 7 (tR = 6.6 min). 
1
H NMR 
(CDCl3): δ = 3.50 (s, 3H, OMe), 4.37 (ddd, J = 9.9, 4.9, and 2.8 Hz, 1H, 5-
H), 4.48 (dd, J = 12.1 and 4.9 Hz, 1H, 6-Hb), 4.62 (dd, J = 12.1 and 2.8 Hz, 
1H, 6-Ha), 4.76 (ddd, J = 10.6, 9.1, and 3.5 Hz, 1H, 2-H), 5.02 (d, J = 3.5 
Hz, 1H, 1-H), 5.76 (t, J = 9.7 Hz, 1H, 4-H), 5.83 (dd, J = 10.6 and 9.5 Hz, 
1H, 3-H), 6.62 (1H, d, J = 9.1 Hz, NH-2), 7.28-7.59 (12 H, overlapping 
signals, benzoyl protons), 7.68 (2H, d, J = 7.8 Hz, benzoyl ortho protons), 
7.90 (2H, d, J = 7.9 Hz, benzoyl ortho protons), 7.93 (2H, d, J = 7.9 Hz, 
benzoyl ortho protons), 8.06 (2H, d, J = 8.0 Hz, benzoyl ortho protons); CD 
(MeCN): λmax (Δε) = 231 nm (+4). 
 
Catalytic Reduction and Methanolysis of Compound 1a: Compound 1a 
(0.5 mg) was dissolved in 1 mL of EtOH, and a small amount of PtO2 was 
added. The suspension was kept under H2 at 1 atm for 12 h, then filtered on 
TITAN PTFE (0.2µm), and taken to dryness. The residue was dissolved in 1 
mL of 1 n HCl in 92% MeOH, and the obtained solution was kept for about 
12 h at 80°C. The resulting mixture was dried under nitrogen and 
benzoylated with benzoyl chloride (100µL) and pyridine (1mL) and purified 
by HPLC [column: Luna SiO2, 5µ; eluent: n-hexane/i-PrOH (99:1); flow: 
1mL min
-1
].  
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 (2S,3S,4R)-1,3,4-O-Benzoyl-2-benzoylamino-1,3,4-octadecanetriol (10): 
CD (MeCN): λmax = 233 (Δε = –1), 222 (Δε = +2) nm. The 1H NMR 
spectrum was identical to that of an authentic sample of D -ribo-
phytosphingosine perbenzoate.
6
 
 
Methanolysis of Amphiceramide B and analysis of methyl glicosides: 
Amphiceramide B (2b, 0.7 mg) was subjected to acidic methanolisys as 
described above for compound 1b. The reaction mixture was dried under 
nitrogen and benzoylated with benzoyl chloride (100µL) and pyridine 
(1mL) at 25 
o
C for 16h. The reaction was quenched with MeOH and dried 
under nitrogen. The residue was then purified by HPLC [column: Luna 
SiO2, 5 μ; eluent: n-hexane/iPrOH (99:1); flow: 1 mLmin–1; UV detector: 
260 nm] and two peaks were identified as methyl tetra-O-benzoyl-α-D- 
glucopyranoside (10) (tR = 28.8 min) and methyl tetra-O-benzoyl-α-D-
galactopyranoside (11) (tR = 30.7 min) by a comparison of their retention 
times, 
1
H NMR spectra and CD spectra with those reported. 
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Table 7: 
1
H and 
13
C NMR spectroscopic data of amphiceramide A 1a (Py) 
 
 
a. Overlapped signals 
 
 
 
Position  δH  (mult, J (Hz))
 δC (mult)  
1 a 4.75
a
 69.8 (CH2) 
 b 4.50  (dd, 10.3, 3.5)  
2  5.27
a 
51.2 (CH) 
2-NH  8.55 (d, 8.9) - 
3  4.33
a 
75.1 (CH) 
4  4.28  (m) 72.4 (CH) 
5 a 3.02 (m) 37.2 (CH2) 
 b 2.68 (m)  
6  5.97 (ddd, 6.9, 15.2, 6.9) 127.8 
7  5.70 (ddd, 6.9, 15.2, 6.9) 132.5 
8  2.03 (m) 32.9 (CH2) 
9-15  1.27
a
 29.8 (CH2) 
16, 20'''  1.31
a
 32.0 (CH2) 
17, 21'''  1.25
a
 22.7 (CH2) 
18, 22'''  0.86
a
 14.1 (CH3) 
1'  4.85
 
(d, 7.7)
 
 104.7 (CH) 
2'  3.93
a
 71.3 (CH) 
3'  4.11  (m) 77.8 (CH) 
4
'  
3.94
a
 74.6 (CH) 
5'  3.95
a
 76.8 (CH) 
6' a 4.75
a 
69.7 (CH2) 
 b 4.14 (dd, 11.2, 6.3)
 
 
1''  5.25 (d, 8.3) 102.7 (CH) 
2''  4.53 (br. t, 8.1)
 
57.6 (CH) 
2''-NH  8.92 (d, 7.5)  
3''  4.40  (m) 76.2 (CH) 
4''  4.21  (m) 72.0 (CH) 
5''  3.91
a
 78.1 (CH) 
6'' 
a 
b 
4.47 (m) 
4.32
a
 
62.2 (CH2) 
 
1'''  -  175.7 (C) 
2'''  4.57 (m)
 
72.1 (CH) 
3''' a 2.18
a
 35.2 (CH2) 
 b 1.94 (m)  
4''' a 1.67 (m) 25.7 (CH2) 
 b 1.75 (m)  
NH-Ac CO 
CH3 
- 
2.17 
171.2 
23.1 
Amphiceramides A and B from the Sponge Amphimedon compressa
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Table 8: 
1
H and 
13
C NMR spectroscopic data of amphiceramide B 2a (Py) 
 
Position  δH  (mult, J (Hz))
 δC (mult)  
1 a 4.75  (dd, 10.3, 6.3) 70.4 (CH2) 
 b 4.43
a
  
2  5.26
a 
51.1 (CH) 
2-NH  8.57 (d, 10.4) - 
3  4.35 (m) 75.2 (CH) 
4  4.28
a
 72.5 (CH) 
5 a 3.02 (m) 37.1 (CH2) 
 b 2.69 (m)  
6  5.98 (ddd, 6.9, 15.1, 6.9) 128.0 (CH) 
7  5.71 (ddd, 6.4, 15.1, 6.4) 132.4 (CH) 
8  2.03 (m)  33.0 (CH2) 
9-15  1.33
a
 29.7 (CH2) 
16, 20'''  1.20
a
 32.0 (CH2) 
17, 21'''  1.23
a
 22.7 (CH2) 
18, 22'''  0.84 (t, 5.1) 14.1 (CH3) 
1'  4.85
 
(d, 7.7)
 
 105.2 (CH) 
2'  3.91 (d, 7.7) 74.7 (CH) 
3'  4.10
a
 78.0 (CH) 
4
'  
4.06 (t, 5.9) 71.2 (CH) 
5'  3.95 (br. t, 8.2) 77.1 (CH) 
6' a 4.81 (br. d, 11.3)
 
69.6 (CH2) 
 b 4.25 (dd, 11.3, 6.3)
 
 
1''  4.99 (d, 7.8) 105.7 (CH) 
2''  4.49 (t, 7.8)
 
72.4 (CH) 
3''  4.17 (br. s) 74.9 (CH) 
4''  4.53  (m) 70.1 (CH) 
5''  4.06 (br. dd, 14.1, 6.9) 76.7 (CH) 
6'' a, b 4.41
a
 62.2 (CH2) 
1'''  -  170.5 (C) 
2'''  4.58 (m)
 
72.1 (CH) 
3''' a, b 1.97
a
 35.5 (CH2) 
 
a. Overlapped signals 
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Chapter 7 
Sponge-microbe associations  
Different types of Demonspongiae, such as the Caribbean sponge Plakortis 
simplex, are associated with endosimbiotic micro-organisms and these 
symbionts contribute to 38-57% of the total sponge biomass.
1
 Bacteria and 
fungi are mostly present in the mesohyl, which contains heterotrophic 
(eubacteria, archea) and some autotrophic bacteria. As sponge-microbe 
interactions are widespread and some bacteria seem to be specific and 
permanently associated with the sponges, the existence of sponge-bacteria 
symbiosis is well established. The sponge-symbiont relationship can be 
categorized into obligatory mutualism (i.e. the symbiont play an essential 
role in the metabolism of their host), facultative mutualism (they have a 
beneficial effect on their host, but the host will survive without the 
symbiont) or commensalism (they are present without obvious beneficial 
effects to their host).  
According to the literature, possible aims of sponge-microbe symbiosis are: 
 Providing nutrition through intracellular digestion or translocation of 
metabolites
2 
 
 Access of new products via nitrogen fixation3  
 Stabilization of the sponge skeleton4 
 Prevention against predation or fouling through secondary 
metabolite production
5
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7.1 Cellular localization of metabolites from P.simplex 
The bacterial content in Plakortis simplex is particularly high, around 90 
bacteria per sponge cell, which are permanently associated with the host. 
The isolation of bacteriohopanoids
6
 that are typical bacterial metabolites, 
from the sponge led to the hypothesis that not only these compounds but 
also the other characteristic metabolites isolated from P. simplex, such as the 
antimalarial polyketide plakortin
7
 and several unusual glycolipids,
8,9
 may be 
produced by its symbionts.  
 
 
     Figure 40: Transmission electron micrograph (TEM) of the P. simplex mesohyl.  
      S. sponge cell, n. sponge cell nucleus, b. bacteria. Scale bar 2 µm 
 
This hypothesis was first tested by localizing specific metabolites in 
cells using physical separation of sponge cells, bacteria and extracellular 
matrix by differential centrifugation.
10
 The obtained fractions were 
separately analyzed for the typical Plakortis simplex metabolites by NMR 
and mass spectrometry.  The results suggested that bacterial symbionts are 
the producers of most of the secondary metabolites isolated from Plakortis.  
s 
n 
b 
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Figure 41: Results of differential centrifugation analysis  
 
In fact, hopanoids and glycolipids were found only in bacterial cells, 
while the polyketide plakortin and its derivatives were present in both 
bacteria and sponge cells. However, the amounts were considerably 
different, as the bacteria fraction contained five times as much plakortin as 
the sponge cell fraction. All the metabolites were also present in the 
extracellular matrix, either because the metabolites are excreted, or because 
part of the cells producing them are lysed during the cell separation process.  
The bacterial origin of these metabolites may be the key to overcome 
the problem of the limited availability of sponge material, which rises every 
time the commercial production of a marine compound of pharmaceutical 
interest from a sponge is hypothesized. If the metabolite is produced by a 
bacterium, then large-scale laboratory culture is possible, and the need to 
harvest sponges from their natural environment is eliminated.  
In the attempt to identify the microorganisms producing the metabolites 
found in P. simplex, over 150 strains were isolate from the pool of its 
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symbionts; 30 representative species were cultivated and subjected to 
chemical analysis in search of glycolipids and plakortin. Unfortunately, we 
could not find the metabolites in any strains. These results were not 
surprising, because it has been estimated that less than 1% of marine 
microbes are cultivable in the laboratory today, and this is even more true 
for symbiotic bacteria. In addition, it is not uncommon that biosynthetic 
gene clusters remain silent unless some particular culture conditions are 
met. Therefore, a culture independent approach was explored, the search for 
genes responsible for the production of the antimalarial polyketide 
plakortin. The final aim of this research is to transfer the plakortin genes 
into a bacterial host, which would become capable of biosynthesizing 
plakortin, and would allow its production on large scale through a 
fermentative process. 
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Chapter 8 
Plakortin 
Malaria is one of the major causes of mortality in the tropical regions. 
Each year, there are approximately 515 million cases of malaria, killing 
between one and three million people, the majority of whom are young 
children in Sub-Saharan Africa. Although some are under development, no 
vaccine is currently available for malaria; preventive drugs must be taken 
continuously to reduce the risk of infection. These prophylactic drug 
treatments are often too expensive for most people living in endemic areas. 
Chloroquine is very cheap and, until recently, was very effective, which 
made it the antimalarial drug of choice for many years in most parts of the 
world. However, resistance of Plasmodium falciparum to chloroquine has 
spread recently from Asia to Africa, making the drug ineffective against the 
most dangerous Plasmodium strain in many affected regions of the world. In 
those areas where chloroquine is still effective it remains the first choice. 
Unfortunately, chloroquine-resistance is associated with reduced sensitivity 
to other drugs, such as quinine and amodiaquine.  
The more recently discovered artemisinin, a sesquiterpene endoperoxide 
from Artemisia annua, is active against Plasmodium falciparum and 
chloroquine resistant strains. Artemisinin and its semisynthetic liposoluble 
(artemether and artether) and water soluble (artesunate) derivatives are 
characterized by a 1,2,4-trioxane (6-membered ring containing 3 oxigen 
atoms) that is the essential pharmacophoric group for their activity. Even
Plakortin 
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 though its mechanism of action hasn’t been exactly determined yet, there is 
experimental evidence that the artemisinin endoperoxide function reacts 
with the heme iron atom. The reaction yields an oxygen radical, and after a 
rearrangement a carbon radical. This alkylating species could be responsible 
for the antimalarial activity. 
 
 
 
        
 
 
                         
 
               Figure 42: Mechanism of action of artemisinin 
 
Fe
II
PPIX 
+ 
1,5 Shift C-C Cleavage 
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The problem with this compounds is their neurotoxic activity which is 
related to the endoperoxide ring; for this reason new antimalarial 
compounds are required that could be easier synthesized, preserved and 
safer.  In this respect, several secondary metabolites from sponges show an 
endoperoxide ring similar to that of artemesinin. Therefore, these 
compounds are being tested in order to evaluate their possible antimalarial 
activity. The first active compound, isolated in 1978 by Faulkner et al. in the 
lipophilic extract of the sponge Plakortis halicondroides, is plakortin, 6-
membered cyclic endoperoxide.  
 
 
Figure 43: Plakortin 
 
Most polyketides that are appearing in the literature have some common 
key features: they all contain a 1,2-dioxane ring with an acetate residue at 
position 3 and alkyl chains at positions 4, 6, and 6. Related molecules with a 
5-membered peroxide ring (1,2-dioxolane), such as Plakortide E, were also 
discovered.  The analysis of the lipophilic extracts of the Caribbean sponge 
Plakortis simplex proved that plakortin is the major constituent of this 
fraction (20%) together with 9,10-dihydroplakortin and the 5-membered 
Plakortide E. 
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Figure 44: Dihydroplakortin (a) an Plakortide E (b) 
 
These three metabolites were tested for their antimalarial activity on 
D10 strains and on W2 (chloroquine-resistant). Bacterial growth was 
evaluated spectrophotometrically (OD650), measuring the pLDH activity 
according to the method by Makler and Hinrichs. Both plakortin and 
dihydroplakortin have a good antimalarial activity, while plakortide E is 
inactive, proving that a six-membered peroxide ring is essential for activity. 
Plakortin is very active on the chlorochine-resistant W2 strain because 
endoperoxide compounds are active against Plasmodium falciparum with a 
different mechanism compared to chloroquine. The biological target of 
plakortin is similar to that of artemisinin, but the former shows a lower 
activity, probably related to its 1,2-dioxane ring instead of the 1,2,4-trioxane 
of artemisinin. In fact, it seems that the oxygen not involved in the peroxide 
moiety can make the radical production easier, increasing the antimalarial 
activity. In spite of its lower activity, its simple structure and insignificant 
cytotoxicity make plakortin a very interesting compound. 
a) 
b) 
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8.1 The biogenesis of plakortin 
The studies about cellular localisation showed plakortin to be present mostly 
in the bacterial cells. Because any attempt to isolate the strain of bacteria 
responsible for the biosynthesis of plakortin, a culture independent approach 
is being currently explored, searching in the metagenomic (sponge + 
symbiont) DNA from P. simplex the gene responsible for the biosynthesis of 
the plakortin.  
The chance of success of this approach comes from the bacterial origin 
of plakortin in that: 
 In bacteria, the genes for the biosynthesis of metabolites are often 
grouped in clusters 
 There are no introns, and this allows to express the genes directly 
from chromosome  
 The compactness of the genome makes it faster to identify the gene 
clusters and to transfer them to hosts for expression 
 Large-scale production of metabolites is possible through 
fermentation 
Moreover, plakortin is a polyketide, and polyketides are biosynthesized 
by polyketide synthases (PKS), enzyme complexes which are widespread in 
bacteria and are very well studied.  
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8.2 Polyketide Synthases 
PKSs are large (100-10000 KDa) multienzymatic systems responsible 
for the production of extremely complex natural products from simple 
blocks with 2, 3 or 4 carbon atoms such as acetyl-CoA, propionyl-CoA, 
butyrril-CoA and their activated derivatives malonyl-, methylmalonyl- and 
ethylmalonyl-CoA. They show strong genetic, structural, and mechanicistic 
similarity with fatty acid synthases. The key step in the biosynthesis of 
polyketides is chain elongation, obtained through Claisen condensation and 
decarboxylation. Unlike fatty acid biosynthesis, in which every chain 
elongation step is followed by a fixed sequence of ketoreduction, 
dehydration, and enoylreduction, the reaction intermediate obtained during 
the polyketide biosynthesis are subjected to none, some or all these 
modifications, yielding very complex products. An added degree of 
complexity comes from the possible use of different starter and elongation 
groups as well as from the formation of new stereogenic centres. 
In the microbial kingdom, three types of PKSs were identified that 
differ in the architecture: 
 Type I PKSs: large multifunctional proteins, which can be either 
modular (erythromycin, rapamycin and rifamycin) or iterative 
(lovastatin). Iterative PKSs are involved in the biosynthesis of 
polyketides such as 6-methyl salicylic acid and aflatoxin in fungi; 
these multidomain proteins include all the active sites for the 
biosynthesis of the polyketide and they reuse domains in a cyclic 
fashion like the fatty acid synthases.  
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 Type II PKSs: they show active sites similar to those of type I PKSs, 
but they are distributed on different small monofunctional peptides. 
They are involved in the biosynthesis of bacterial aromatic 
compounds such as doxorubicin 
 Type III PKSs: iterative PKSs responsible for the production of 
chalcones and stilbenes in plants and polyhydroxy phenols in 
bacteria. Chalcone synthases consisting of a single polypeptide chain 
do not show ACP domain, and their substrates are directly CoA 
derivatives. 
Modular PKSs are very interesting enzymes; they contain a sequence of 
separate modules; a module consists of not repeated catalytic domains with 
defined function separated by short spacer regions.  Each module is 
responsible of one step of polyketide elongation and of modification of 
functional groups.  
The most common catalytic domains found in PKSs are: 
 Acyltransferase (AT): this enzyme transfers the elongation group 
(malonyl or a malonyl derivative) from CoA to the ACP module.  
This module is responsible for the selection of the proper elongation 
group. 
 Acyl Carrier Protein (ACP): this domain binds the elongation group 
and, after the Claisen condensation, the growing chain through the 
distal –SH group of the 4’- phosphopantetheine arm. This protein is 
biosynthesized as an inactive form and after translation binds to 4’-
phosphopantetheine through a serine residue 
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 Ketosynthase (KS): catalyzes the displacement of the growing 
polyketide chain from the ACP domain of the previous module to an 
–SH in the KS domain itself, and then the decarboxylative Claisen 
condensation with the elongation group linked to the ACP domain of 
the current module, leading to a β-ketoacyl. 
 Ketoreductase (KR): this NADPH-dependent domain catalyzes the 
reduction reaction of the β-ketoacyl to a β-hydroxy acyl. 
 Dehydratase (DH): this enzymatic subunit catalyzes the removal of a 
water molecule from the β-hydroxy acyl with the formation of a 
double bond. 
 Enoylreductase (ER): catalyzes the reduction of the double bond 
produced by the DH domain 
 Thioesterase (TH): this domain is present only in the last module, 
and catalyzes the release of the polyketide from the last ACP 
domain.  
All the modules are at least composed of a KS, an AT, and an ACP 
domain. Moreover, specific combinations of KR, DH, ER (and also 
epimerase and methyltransferase) domains can be present in each module. 
Due to the non-iterative nature of these enzymes, it is possible to predict the 
structure of the polyketide produced by a PKS on the basis of the number of 
modules of the PKS and the domains present in each module. Conversely 
(and more interestingly from our point of view) it is possible to predict the 
PKS organization on the basis of the structure of the polyketide. 
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8.3 An Hypothesis on the Biogenetic Pathway to Plakortin 
As discussed in previous section, plakortin is presumably biosynthesized by 
a Type I PKS. 
 
Figure 45: Biogenetic dissection of plakortin 
 
Looking at the structure of plakortin, it is quite apparent that carbon 
skeleton should be produced by condensation of three butyrate, one 
propionate, and one acetate units. Alternatively, the C4 unit at the end of the 
molecule could arise from two acetate units instead of one butyrate. The 
reactions that lead to the formation of plakortin can be grouped into four 
cycles (corresponding to four modules of a PKS), each composed of several 
steps catalyzed by different catalytic domains. As in all modular and non-
iterative PKS, the synthesis proceeds through a cascade mechanism and the 
reaction product of each reaction is the substrate for the next reaction.  
Based on the above discussion, the reaction sequence for the 
biosynthesis of plakortin can be hypothesized as follow: 
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Figure 46: The cascade mechanism hypothesized for the biosynthesis of plakortin  
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Loading 
The loading stage consists of three steps. First, the loading AT domain 
transfers the starter group from ethylmalonyl-CoA to the –SH group of the 
ACP domain, followed by decarboxylation to give butyryl-ACP.  
 
Cycle 1 
The elongation group is loaded by the current AT domain onto the ACP 
domain, yielding ethylmalonyl-ACP. The ACP-bound elongation group 
reacts with the butyryl residue bound the ACP of the starting module in a 
Claisen condensation and decarboxylation, catalyzed by the KS domain. 
The obtained β-ketoacyl group is reduced to β-hydroxy by the KR domain. 
Then, the DH domain splits off a water molecule, resulting in the α,β-
unsaturated thioester (intermediate A) which is the substrate for the 
subsequent enzymatic reactions.  
 
Cycle 2 
The second cycle is similar to the first one, but in this case the AT domain 
loads a methylmalonyl-CoA molecule instead of ethylmalonyl-CoA onto the 
ACP module. The decarboxylative Claisen condensation (KS) is followed 
by reduction (KR), dehydration (DH) reactions and by the α-β double bond 
reduction, catalyzed by ER domain (intermediate B). 
 
Cycle 3 
The KS domain catalyzes the condensation between compound 2 and 
ethylmalonyl residue on the ACP domain. The β-ketoacyl group of the 
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growing chain is reduced and the subsequent β-hydroxyacyl dehydration 
yields the intermediate C.  
 
Cycle 4 
The AT domain loads a malonyl-CoA onto the ACP domain. The Claisen 
condensation and decarboxylation (KS) between malonyl-ACP and the 
intermediate C followed by reduction (KR) and dehydration (DH) produces 
the intermediate D. 
 
Oxidative Cyclisation   
As in literature there are not comparable examples, it is difficult to 
hypothesize an accurate mechanism of oxidative cyclisation. The reaction 
could take place in the presence of singlet oxygen through a Diels-Alder 
type mechanism. This reaction yields the intermediate E and, after the 
reduction of the double-bond and hydrolysis of the thioester, plakortin.  
Therefore, the organization of PKS for plakortin is probably as 
sketched below. The PKS could be composed in one or more polypeptide 
chains, and therefore could be coded by one ore more clustered genes. 
 
 
 
Figure 47: Hypothesized organization of the PKS for plakortin 
 
 
Module 2 Module 1 Loading Module 
Module 3 Module 4 
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8.4 Strategy for the Identification of Plakortin Biosynthetic 
Gene Cluster  
In order to isolate plakortin gene cluster, a library of metagenomic DNA 
(DNA for sponge and DNA from symbiotic microorganisms) from Plakortis 
was constructed. DNA was isolated from the sponge, sheared and inserted in 
fosmid vectors, which were used to transform competent E. coli cells (i.e. 
cells which are capable to and replicate the fosmids). Dealing with a 
metagenome, estimation of the number of the genomes of their size is 
impossible, and therefore the library should be as large as possible.  
Generally speaking, the selection of recombinant clones may be based 
on: 
 DNA sequence: screening with hybridization or PCR 
 Protein sequence: immunological screening 
 Biochemical function: screening based on the polypeptide function 
 Peptide ability to interact with other polypeptide: screening for 
interaction 
In our case there was no guarantee about plakortin gene expression in 
the host, and therefore PCR-based screening of nucleotide sequence was 
used. PCR (Polymerase Chain Reaction) allows amplification of a specific 
piece of DNA exponentially, and is effective even if only a trace amount of 
the target DNA fragment is present in the metagenome. The couple of 
primers can be directly tested on the whole metagenome before the 
screening of the library. However, the design of appropriate primers 
requires prior knowledge about the sequence to amplify. 
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Plakortin fits this strategy very well. PKS are widespread in bacteria, 
and the sequences of many PKS genes are available in literature, showing 
conserved regions common to all modules and presumably also to plakortin 
PKS. Another reason why plakortin was chosen as a target is that it is 
mainly composed of butyrate and propionate, rather than acetate, units, and 
therefore is presumably biosynthesized by a quite peculiar PKS. Because the 
selection of methylmalonyl-CoA or ethylmalonyl-CoA depends on the AT 
domain, the sequences of many AT domains with different selectivity were 
compared. These domains show: 
 Conserved regions common to all domains 
 Signature regions: regions which are different in AT domains 
specific for different substrates (malonyl-CoA, methylmalonyl-CoA, 
ethylmalonyl-CoA) 
Conserved regions were used to design a couple of "generic" primers 
suitable for all AT domains, regardless of their selectivity. As butyrate- 
specific AT domains are uncommon, specific primers were also designed, 
on the basis of the signature regions of propionate and butyrate-specific AT 
domains, so as to increase the chance to isolate plakortin PKS gene cluster 
among all the PKS genes in the metagenome. 
After PCR screening, the selected fosmids need to be sequenced and 
their sequences analyzed to confirm their compatibility with the structure of 
the polyketide. PKS for plakortin should contain 4 or 5 modules and so its 
size should be comparable to the DNA insert contained in each fosmid 
(around 40Kb). This could make it possible, although not likely, to find the 
whole gene cluster inside a single fosmid. 
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The final purpose of this study is to express the plakortin gene 
cluster in a heterologous host. Heterologous expression of polyketides is 
currently a pioneering research area. Although an increasing number of 
examples are being reported in the literature, a number of problems remain 
to be resolved, such as the choice of the most suitable host, and the frequent 
need to provide the host with the additional biosynthetic machinery which is 
needed for post-translational modification of the PKS and for supply of 
biosynthetic precursors. However, a large amount of research is being done 
in this fast-developing field, and heterologous expression is expected to 
become a commercial reality in a few years. 
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Chapter 9 
 
Construction of a Metagenomic DNA Library  
9.1 DNA Extraction 
A small piece of frozen Plakortis in RNA Later (200 mg) was minced 
and suspended in a buffer containing CTAB and SDS as detergents, which  
degrade membranes and release the cellular content in solution, and PVP, 
NaCl and β-mercaptoethanol, with the function of stabilizing the DNA 
molecule and minimizing DNA breakage. The resulted suspension was 
incubated for 3 h at 55 
o
C to allow cell lysis, and then centrifuged to 
precipitate spicules and other insoluble material. A volume of chloroform 
was added to the supernatant, containing DNA, to extract most proteins. 
After centrifugation and removal of the chloroform phase, 100% 
isopropanol (2/3 volumes) was added to the aqueous phase to precipitate 
DNA. After centrifugation, the supernatant was discarded and DNA was 
washed twice with 70% EtOH, air-dried for a few minutes, and re-dissolved 
in a diluted TE buffer. 
The amount of DNA was evaluated spectrophotometrically by 
measuring the absorbance of the sample at 260 nm, the absorption 
maximum of nucleic acids. 
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9.2 Construction of the Gene Library  
After extraction, metagenomic DNA was used to construct a fosmid 
library using the CopyControl
TM
 Fosmid Library Production Kit (Epicentre). 
A gene library is a population of bacterial colonies, each carrying a different 
DNA fragment that is inserted in a cloning vector. There are many types of 
cloning vectors which can be used to build genomic library. Plasmids are 
circular and double-stranded extra-chromosomal DNA molecules that are 
capable of replicating independently of the chromosomal DNA. Cosmids 
are hybrid plasmids. They contain the cos sequences from the Lambda 
phage, which allow the recognition by the phage capsid proteins. In this way 
cosmids, packaged into capsids, can be easily transferred into bacterial cells 
where they can replicate as plasmids, so that many copies of cosmids can be 
present in each bacterial cell. Cosmids are able to contain 37 to 52 kbp of 
DNA while normal plasmids carry only 1-20 kbp. Fosmids are more 
sophisticated than cosmids; they are derived from the bacterial plasmid F, 
and contain a partitioning and replication system which allows the bacterial 
host (E. coli) to contain a single copy of the fosmid, offering a higher 
stability to the library.  
The CopyControl pCC1FOS vector, which was used to build 
metagenomic DNA fosmid library from Plakortis simplex, has distinctive 
features, such as chloramphenicol-resistance for selection of the transformed 
bacterial cells, and the inducible high-copy oriV origin of replication in 
addition to the single-copy origin. Initiation of replication from oriV 
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requires an inducer, and can be activated during the fosmid isolation to 
increase its amounts.   
The following steps were involved in P. simplex DNA library 
construction: 
 DNA extraction and purification  
 Random shearing of the DNA to approximately 40 Kb fragments 
 End-repair reaction of the sheared DNA to blunt, 5'-phosphorylated 
ends 
 Size selection of end-repaired DNA by LMP (low melting point) 
agarose gel electrophoresis 
 Ligation of blunt end DNA to the CopyControl pCC1FOS vector 
 Packaging of ligated DNA and transformation of EPI 300-T1R 
competent cells 
 Plating of transformed cells and antibiotic selection of positive 
clones 
 Picking of selected fosmid clones and screening  
 
End-Repair 
During this step DNA fragments ends, which could have been damaged 
during DNA extraction and shearing, were repaired and 5'-phosphorylated. 
A reaction mixture containing End-repair 10X Buffer, dNTPs, ATP, and 
End-repair Enzyme Mix was added to the appropriate volume of DNA 
solution in TE Buffer. End-repair Enzyme Mix contains T4 polynucleotide 
kinase which catalyses γ-phosphate transfer from ATP to free –OH groups 
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at DNA 5'-position and T4 polymerase with both 5'    3' polymerase and      
3'   5' exonuclease activities.  
Reaction was incubated at room temperature and then at 70
o
 C for 10 
minutes to inactivate End-repair Enzyme mix.  
     
 
 
 
 
 
 
Figure 48: Metagenomic DNA Library Construction 
 
Size Selection 
Size selection of DNA fragments is required before ligation. The 
optimal fragment size is around 40 Kb according to the capacity of fosmid 
cloning vector. It is important that the DNA recovered is ≥ 25 Kb in order to 
avoid unwanted chimeric clones.  
End-repaired DNA was size selected by low melting point (LMP) 
agarose gel electrophoresis. GELase, an enzyme responsible for hydrolyzing 
β-agarose leaving nucleic acids intact, was used to extract the DNA 
fragment (1.2 µg) of correct size back from the gel matrix. 
Packaging 
Transformation 
and plating 
Ligation 
Metagenomic DNA 
DNA shearing pCC1FOS vector 
40 Kbp DNA 
+ 
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Ligation 
During ligation size-fractionated DNA (0.25 µg) was inserted into 
the pCC1FOS vector. Ligation involves creating a phosphodiesther bond 
between double-stranded DNA molecules having 3'-hydroxylated and 5'-
phosphorylated blunt ends. Fast-Link DNA Ligase was used for this 
purpose, which originates from the T4 bacteriophage. 
  
Packaging 
After ligation fosmids were mixed with the capsid proteins (MaxPlax 
Lambda Packaging Extract) of bacteriophages, giving phage particle 
capable to transfer the fosmid into bacterial cells. Titering of this mixture 
showed packaged fosmid clones concentration of 50.000 CFU/mL. 
 
Transformation 
Transformation is the process by which competent bacterial cells 
take up foreign DNA molecules and allow its replication and expression. 
When DNA is transferred to one bacterium by a virus, transformation is 
called transduction. During transduction bacteriophages attach to a specific 
receptor on the bacterial cell’s surface through tail fibers. Lysozyme 
dissolves a hole in the cell wall, the phage contracts and the nucleic acid is 
injected into the cell.  
Serial dilution of phage particles (packaged fosmid clones) into 
Phage Dilution Buffer (PDB) were mixed with EPI 300-T1
R
 host cells and 
incubated at 37
o
 C for 20min. Then the infected bacteria were spread on LB 
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plates + 12.5 µg/mL chloramphenicol and incubated overnight to select the 
fosmid clones.  
The bacterial colonies grown on the plates were transferred in 96-
well plates containing 300 μL of LB medium + chloramphenicoland and 
subjected to PCR technique to evaluate the presence of the plakortin gene 
cluster. 
              
Figure 49: Metagenomic DNA Library from Plakortis simplex 
 
9.3 PCR Screening 
The Polymerase Chain Reaction, developed by Kary Mullins in 1984, is 
a widely used technique for a variety of application like DNA cloning and 
sequencing, the diagnosis of hereditary disease, and the identification of 
genetic fingerprint in forensic science. It allows to exponentially amplify a 
single or few copies of a specific sequence of DNA, called target sequence, 
from a mixture without any purification  
DNA molecules are melted by raising temperature to 90-95
o
 C 
(denaturation); after the helixes are separated, the temperature is lowered to 
45-65
o 
C, so that a pair of short oligonucleotide (primers), specific for the 3'-
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ends of the target sequence can bind to the appropriate strands of DNA, one 
primer on each strand (annealing). The primers direct the DNA polymerase, 
called Taq, to synthesized complementary DNA strands from free 
nucleotide triphosphates (extension/elongation). In the entire mixture, only 
the DNA containing the target sequence is duplicated, because the Taq 
polymerase can only duplicates molecules having the primers attached. 
These three phases are repeated 20-40 times, and the number of target 
sequences doubles at each cycle.  
One of the most important factors affecting the quality and the 
selectivity of PCR is the choice of primers: they need to match as closely as 
possible the beginning and the end of the DNA fragment to be amplified, so 
as to anneal to these starting and ending points exclusively. DNA 
polymerase binds to them and begins the synthesis of the new DNA strands.  
A pair of generic primers, designed on the conserved amino acid 
sequences of Type I PKSs AT domains were used in the screening of a 
preliminary metagenomic DNA library from Plakortis, constructed as a test.  
 
 
 
Figure 50: Signature region identified in PKSs gene clusters from GenBank. 
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Primer Nucleotide Sequence 
Conserved Amino Acid 
Sequence 
PKSAT1F (24bp) 5'-TTYCCIGGICARGGINSSCAGTGG-3' FPGQGSQW 
PKSAT3R2 (18bp) 5'- GCIGCIGCNATCTCNCCC-3' GEIAAA 
 
 
Table 9: Primers for conserved regions of AT domains of type-I PKSs. Y = C+T, 
R = A+G, S = G+C, N = A+G+C+T, I = inosine. 
 
A number of degenerated nucleotides (mixtures of different 
nucleotides) and inosines (inosine can indiscriminately pair with all of A, T, 
C, and G) were use in the synthesis of these primers, because the conserved 
amino acid sequences cannot be univocally translated into nucleotide 
sequences due to codon degeneracy (each amino acid is coded by more than 
one codon). 
Only a single positive clone was obtained called 11G3, that was 
partially sequenced (~4 Kb) by primer walking. It appeared to contain a 
Type I PKS, and the AT domain resembled more closely to 
propionyl/butiryl-specific ATs than the acetate-specific ones.  
 
  
Figure 51: Primer walking result on 11G3 positive fosmid 
 
This partial sequence was used to design two new couples of primers 
specific for this particular PKS (one couple was designed on the AT domain 
and one couple on the KS domain), which were used for the screening of a 
new, larger library in order to obtain more positive fosmids.  
 
                                                Chapter 9
                                               
131 
 
 
Primer Nucleotide Sequence Aminoacid Sequence 
ATPEF (26bp) 5'-ATGGTGTTTTCGGGGCAGGGCACGCA-3' MVFSGQGTQ 
ATPER (30bp) 5'-GGCGGCGGCCACCTCGCCCGAGCTGTGTCC-3' GHSSGEVAAA 
KSPEF (32bp) 5'-AACGAGATGGCGAACATGGATCCGCAGATCCG-3' NEMANMDPQIR 
KSPER (29bp) 5'-CGGTCGCCCACGACGGTGCCGGTCGCATG-3' HATGTVVGDR 
 
Table 10: Primers pairs designed on positive fosmid sequence 
 
So far, over 8.000 of the 50.000 colonies of the library were screened 
using these primers to identify a PKS gene. 
A positive clone has been obtained, called α11D7. It was full sequenced 
by shotgun sequencing, but unfortunately the PKS gene clustes was located 
at one end of the insert, so that only a small part of the gene cluster (about 9 
Kbp) was present in the insert.   
 
Table 11: Open reading frames identified in contig0003 and their putative function 
as identified by BLAST Search CD. 
 
 
 
 
 
bp Conserved domains AA 
44-1114  Glycosyl transferase 356 
1126-2310  Heparinase (?) 394 
5482-6723 Integrase  413 
6723-7628 Integrase 301 
7625-8617 Integrase  330 
8941-9987  WcaG 348 
10471-11847 Sugar Transferase 458 
11858-20813 PKS module (incomplete ORF, see below) 2985 
20814-21658 Vector PCC1FOS  
Construction of a Metagenomic DNA Library 
  
132 
 
 
 
Figure 52: The two biggest contigs from shotgun sequencing of fosmid α11D7. 
Contig0003 contains part of a PKS gene cluster. 
 
The nucleotide sequence was translated in amino acid sequence and 
analyzed with BLAST in search of homologous proteins. BLAST CD 
Search module, used to search conserved domains, revealed the presence of 
the first 9 Kb of a PKS gene, and its AT domain is similar to AmbH gene 
from Polyangium cellulosum, responsible for the biosynthesis of antibiotic 
polyketide ambrucitin. We still do not know whether or not this module is 
related to plakortin. New primers were designed using Primer-BLAST for 
the end region of the known sequence and these are used for screening of 
more fosmid to search the remaining part of the gene cluster. 
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Figure 53: A PKS module in α11D7 positive clone 
 
9.4 Experimental Section 
SB Buffer: 20X SB Buffer was prepared by dissolving 40 g of boric acid in 
90 mL of distilled water, and leaving the solution under magnetic stirring 
for one day. Next day, solid NaOH (around 10g) was added to the solution, 
while monitoring the pH with a pH meter, up to pH 8.3. The SB Buffer was 
autoclaved at 120
o
 C for 20 min, and then a 1:20 dilution was used for gel 
electrophoresis.  
 
TE Buffer: TE buffer was prepared dissolving in 500 ml of distilled water 
the following compounds: 
 10 mM Tris-HCl (pH = 7.5) 
 1 mM EDTA 
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Cell Lysis Buffer: The following compounds were dissolved in 500 mL of 
distilled water: 
 2% CTAB  
 200mM tris HCl pH 8 
 50mM EDTA 
 1.4M NaCl 
 0.5% PVP 
 
LB Medium + Chloramphenicol: In 500 mL of distilled water, 12.5 g of LB 
medium (Sigma) were dissolved. The solution was sterilized in autoclave at 
120
o
 C for 20min. After cooling to 55
o
 C, 250 µL of a 25 µg/mL 
chloramphenicol solution in 96% ethanol were added. 
 
LB Medium + Chloramphenicol - Agar Plates: 12.5 g of LB and 7.5 g of 
agar powder (Fluka) were dissolved in 500 mL of distilled water, and after 
autoclaving and cooling to 50 °C, the chloramphenicol solution described 
above was added. After mixing, the medium was poured into 100mm, sterile 
Petri dishes. The plates were allowed to cool down to room temperature and 
then stored at 4 
o
C.  
 
Metagenomic DNA Extraction: 190 mg of Plakortis simplex tissue, stored 
in RNA Later at -80 
o
C, was minced in small piece and subjected to cellular 
lysis with the following reagents: 
 cell lysis buffer (18 mL)  
 10% SDS (180 µL) 
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 β-mercaptoethanol (90 µL) 
The suspension was kept at 55 
o
C for 3 h, mixing by inversion every 30min. 
the tube was spun for 4min at 4500rpm to remove spicules and other 
insoluble material (white cotton-like precipitate). The supernatant (17.1 ml), 
containing the DNA, was gently transferred to a clean tube. One volume of 
chloroform was added and the solution was mixed by shaking, in order to 
separate DNA from proteins, soluble in chloroform. The tube was spun for 
20min at 4500rpm at room temperature. The upper aqueous phase (15.3 mL) 
was again washed with chloroform. After centrifugation 100% isopropanol 
(9.5 mL, 2/3 vol.) was added to the aqueous phase (14.2 mL) and the 
solution was mixed by inversion several times to precipitate DNA.  The tube 
was spun for 10 min at 4500 rpm. A thick pellet formed. The supernatant 
was removed and the pellet was washed twice with 70% ethanol. The tube 
was spun at 4500 rpm for 4 min. The ethanol was discarded and the pellet 
was air-dried for 30 min, than dissolved in 250 µL of TE Buffer. The 
amount of obtained DNA was evaluated spectrophotometrically. 
 
 
Figure 54: UV spectrum of DNA (1:50 dil., 400 µL) extracted from Plakortis 
simplex. A260 = 0.35, A280 = 0.22, ratio = 1.6, 875 ng/µL, c = 1 cm  
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Shearing and End-Repair: Purified DNA was randomly sheared through 
the tips of a pipette (100 µL) for around 100 times. Sheared DNA was 
subjected to End-Repair reaction according to the CopyControl Fosmid 
Library Production Kit (Epicentre) procedure. The following reagents were 
thaw on ice and mixed: 
 0 µL sterile water 
 8 µL 10X End-Repair Buffer 
 8 µL 2.5 mM dNTP Mix 
 8 µL 10 mM ATP 
 52 µL sheared DNA (~0.5 mg/mL) 
 4 µL End-Repair Enzyme Mix 
(80 µL total reaction volume). Mixture was incubated at room temperature 
for 45 min and then at 70 
o
C for 10 min to inactivate the End-Repair 
Enzyme Mix.  
 
Size Selection of the End-Repaired DNA: 16 µL (1/5 vol.) of 10X Blue 
Juice
TM
 Gel Loading Buffer (Invitrogen) were added to End-Repaired DNA 
solution (80 µL). The mixture was loaded into a low melting point (LMP) 
agarose gel (20 cm long), as follows. This was prepared dissolving 0.36 g of 
LMP agarose (BioRad) in 90 mL of SB Buffer 1X.   
1. HMW Marker    10 µL + 2 µL Blue Juice 
2. DNA not sheared    2 µL + 1 µL Blue Juice 
3. Fosmid Control DNA (1:5)    2 µL + 1 µL Blue Juice 
4. End-Repaired DNA sol.   90 µL  
5. End-Repaired DNA sol.     6 µL 
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The sample was resolved by electrophoresis at room temperature overnight 
at a constant voltage of 45 V.  
                1   2   1         5  4        3   L               
 
Figure 55: Agarose gel electrophoresis of end-repaired DNA. 
 
The next day the lane 5 containing DNA was cut off and separated from the 
gel. The gel was stained with SYBRSafe DNA Gel Stain (Invitrogen) 
solution in 1% SB Buffer 1X and the position of the Fosmid Control DNA 
markers were visualized with UV light. After reassembling the gel a 0.5cm 
wide gel slice containing migrated DNA was excised from the lane 5 just 
slightly above the position of the 36 Kb Fosmid Control DNA markers. 
DNA was then extracted from the gel slice, as follows.  
 
Recovery of the Size-Fractionated DNA from Agarose Gel: The gel slice 
(340.6 mg), containing the DNA of correct size was incubated at 70 
o
C for 
15 min to melt the LMP agarose and then at 45 
o
C. 3.4 µL of GELase 
Enzyme Preparation (1 µL for every 100 µL melted agarose) were added 
and the solution was kept at 45 
o
C for one hour. After incubation the 
solution was transferred to 70 
o
C for 10 min to inactivate the GELase 
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enzyme. The solution was chilled in an ice bath for 5 min and then 
centrifuged at 13000 rpm for 20 min to pellet any insoluble 
oligosaccharides. A gelatinous pellet formed. The upper 326.8 µL of the 
supernatant, containing DNA, were removed into a clean microcentrifuge 
tube. The following reagents were added to precipitate the DNA: 
 32.7 µL 3 M Sodium Acetate (pH 7) 
 898.7 µL of 99.6% Ethanol  
The mixture was inverted several times and DNA was allowed to precipitate 
for 30 min at -20 
o
C. It was than centrifuged for 20 min at 13000 rpm. DNA 
pellet was washed twice with 75% EtOH, then dried under laminar flow for 
10 min and redissolved in 25 µL of TE Buffer. 
 
Ligation: The following reagents were thawed on ice, combined and mixed: 
 0 µL ultrapure sterile water 
 1 µL 10X Fast-Link Ligation Buffer 
 1 µL 10 mM ATP 
 1 µL CopyControl pCC1FOS Vector (0.5 µg/µL) 
 6 µL insert DNA (0.25 µg of ~40 Kb) 
 1 µL Fast-Link DNA Ligase 
(10 µL total reaction volume). The mixture was incubated for 2 h at room 
temperature and then transfer to 70 
o
C for 10 min to inactivate Fast-Link 
DNA Ligase. 
 
Packaging: 50 mL of LB + 10 mM MgSO4 were inoculated with a single 
EPI 300-T1
R
 Plating Strain cells and kept under shaking overnight at 37 
o
C. 
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The next day 5 mL of EPI 300-T1
R
 overnight culture were used to inoculate 
45 mL of LB + 10 mM MgSO4. Bacterial growth at 37 
o
C was monitored by 
UV spectroscopy to an OD600 = 0.8. One tube of MaxPlax Lambda 
Packaging Extract was thawed on ice; 25 µL were transferred in a clean 
eppendorf tube and all the 10 µL of the Ligation reaction were added. The 
mixture was mixed by pipetting several times and incubated at 30 
o
C for 90 
min. After the 90 min packaging reaction was completed the remaining 25 
µL of MaxPlax Lambda Packaging Extract, previously thawed on ice, were 
added and the reaction was incubated for an additional 90 min at 30 
o
C. At 
the end of the second 90 min Phage Dilution Buffer was added to 1 mL final 
volume and after mixing 25 µL of chloroform. A viscous precipitate formed, 
which didn’t interfere with library production. 
 
Titering and Transformation: Phage particles in PDB were diluted as 
follows: 
1. 1:101: 1 µL phage particles + 10 µL PDB 
2. 1:102: 10 µL phage particles + 990 µL PDB 
3. 1:103: 10 µL of 1:102 dilution + 90 µL PDB 
10 µL of each dilution were added to 100 µL of the prepared EPI300-T1
R
 
host cells and the suspensions were incubated for 20 min at 37 
o
C. The 
infected EPI300-T1
R 
were spread on LB plates + 12.5 µg/ml 
chloramphenicol. After overnight incubation at 37 
o
C the colonies on 1:10
2
 
dilution plate were 50 therefore the titer of phage particles was about 50.000 
CFU. Colonies were picked from the plates using sterile toothpicks, and 
used to inoculate 96-wells plates, each well containing 250 µL of LB + 12.5 
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µg/mL chloramphenicol in duplicate. The colonies in the same row of every 
plate were pooled in the same well in one new 96-well plate, as shown 
below:  
 
Figure 56: Pooling procedure  
One copy of the pools was stored at -80 
o
C, after adding 50 µL of glycerol 
to each well (200 µL). 
 
High Copy Number Amplification of Fosmid Clones: Before screening the 
fosmids contained in the pool plates were induced to high copy number. 20 
mL of LB medium + 12.5 µg/mL chloramphenicol and 20 µL of 1000X 
CopyControl Induction Solution were mixed and used to load a 96-well 
plate (200 µL in each well). 50 µL from the cultures of one pools were 
added in each well, the plates were shaken for 5 h at 37 
o
C.  
   
PCR Screening: All the colonies from the pools were screened with PCR 
using specific primers for AT and KS modules shown above. The following 
reagents were mixed in a eppendorf tube for PCR (0.2 µL): 
Plate α5 
Pool α 
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1. 8 µL   Master Mix (Eppendorf) 
2. 0.8 µL  Mg2+ 
3. 2.5 µL  forward primer  
4. 2.5 µL  reverse primer  
5. 6.2 µL  sterile H2O 
The thermocycler program was: 
1. 95 oC (cellular lysis)  30 min 
2. 95 oC (denaturation)  30 s 
3. 52 oC (annealing)  30 s 
4. 72 oC (elongation)  1 min 
5. 72 oC (polymerization) 5 min 
6. 4 oC    ∞ 
5 µL of every PCR product were mixed with 1 µL of DNA intercalating 
agent Blue Juice
TM
 Gel Loading Buffer and loaded in the agarose gel (1%). 
PCR products were allowed to migrate for 30 min at 150 V. The only 
positive fosmid has been obtained from 7D well of α11 plate; it was 
extracted using QIAPrep Spin MiniPrep Kit (Qiagen). 
 
Plasmid DNA Purification: The positive colony was picked from the 
selective plate, inoculated in a culture of 5 mL LB medium + 12.5 µg/mL 
chloramphenicol and incubated overnight at 37 
o
C with vigorous shaking. 
The next day in two clean falcons the following reagents were mixed: 
1. 4.5 mL LB + 12.5 µg/mL chloramphenicol 
2. 500 µL fresh overnight culture of α11D7 
3. 5 µL 1000X CopyControl Induction Solution 
32X 
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Positive fosmids were amplified to high copy number at 37 
o
C for 5 h and 
the transformed bacterial cultures were than centrifuged at 10.000 rpm for 
10min. The supernatant was discarded and the pelleted bacterial cells were 
resuspended in 250 µL of P1 Buffer + RNase A. Buffer P2 was added for 
cellular lysis and the suspension was mixed by inverting the tube until the 
color of the solution turned to blue (for the presence of Lyse Blue reagent in 
the Buffer P2). 350 µL of Buffer N3 were added quickly to avoid DNA 
degradation and the suspension was mixed by inverting the tube until all 
trace of blue was gone, that indicated the SDS was precipitated. The 
suspension was then centrifuged for 10 min at 13.000 rpm. The supernatant 
was applied to the QIAprep spin column and centrifuged for 30-60 s. The 
column was washed by adding 0.5 mL Buffer PB and centrifuging for 30-60 
s, and then 0.75 mL Buffer PE and again centrifuging. To elute DNA 50 µL 
Buffer EB were added to the center of each QIAprep spin column and 
centrifuged for 1 min. The obtained fosmid amount was 
spectrophotometrically mesasured. 
